Research graph
References from Platelet-rich therapies in cutaneous and mucocutaneous disorders characterized by inflammatory tissue responses: mechanistic insights and clinical evidence. Local targets link to admitted publications; unresolved targets remain external evidence.
Mucocutaneous diseases
10.1016/j.cden.2019.08.009 · 2020 · External reference
Mucocutaneous disorders
10.1111/j.1600-0757.1998.tb00140.x · 2000 · External reference
Dermatologic and mucocutaneous disorders
10.1007/978-3-030-74720-6_57 · 2024 · External reference
Unresolved reference
2018 · External reference
191 the burden of mental health in inflammatory skin diseases: depression, anxiety, and quality of life in psoriasis, atopic dermatitis, and hidradenitis suppurativa
10.1016/j.jid.2025.09.197 · 2025 · External reference
The burden of skin disease: quality of life, economic aspects and social issues
10.7861/clinmedicine.9-6-592 · 2009 · External reference
The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions
10.1038/jid.2013.446 · 2014 · External reference
Global burden of skin disease: inequities and innovations
10.1007/s13671-017-0192-7 · 2017 · External reference
Psychosocial impact of skin diseases: a population-based study
10.1371/journal.pone.0244765 · 2020 · External reference
Mechanisms regulating skin immunity and inflammation
10.1038/nri3646 · 2014 · External reference
Unresolved reference
2017 · External reference
Unresolved reference
2015 · External reference
The diagnosis and treatment of autoimmune blistering skin diseases
10.3238/arztebl.2011.0399 · 2011 · External reference
Therapeutic strategies focusing on immune dysregulation and neuroinflammation in rosacea
10.3389/fimmu.2024.1403798 · 2024 · External reference
Immune surveillance in the skin: mechanisms and clinical consequences
10.1038/nri1310 · 2004 · External reference
Skin immune sentinels in health and disease
10.1038/nri2622 · 2009 · External reference
Dialogue between skin microbiota and immunity
10.1126/science.1260144 · 2014 · External reference
Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
10.1038/s41577-021-00538-7 · 2021 · External reference
The epithelial barrier theory proposes a comprehensive explanation for the origins of allergic and other chronic non-communicable diseases
10.1002/1873-3468.70113 · 2025 · External reference
The epithelial barrier: the gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions
10.1016/j.smim.2023.101846 · 2023 · External reference
Inside the mucosal immune system
10.1371/journal.pbio.1001397 · 2012 · External reference
Skin immunity and inflammation: cellular interactions and communication
10.1002/cti2.70053 · 2025 · External reference
The dynamics of the skin's immune system
10.3390/ijms20081811 · 2019 · External reference
Mucosal immune response in biology, disease prevention and treatment
10.1038/s41392-024-02043-4 · 2025 · External reference
T(H)-17 cells in the circle of immunity and autoimmunity
10.1038/ni0407-345 · 2007 · External reference
IL-17 and Th17 cells
10.1146/annurev.immunol.021908.132710 · 2009 · External reference
Th pathways in immune-mediated skin disorders: a guide for strategic treatment decisions
10.4110/in.2024.24.e33 · 2024 · External reference
The central roles of keratinocytes in coordinating skin immunity
10.1016/j.jid.2024.06.1280 · 2024 · External reference
Skin barrier dysfunction in chronic dermatoses: from pathophysiology to emerging therapeutic strategies
10.7759/cureus.86937 · 2025 · External reference
Synopsis of barrier function of skin and oral mucosa-volume 1
10.3390/ijms22179383 · 2021 · External reference
Synopsis of barrier function of skin and mucosa-volume 2
10.3390/ijms241813690 · 2023 · External reference
Epithelial antimicrobial defence of the skin and intestine
10.1038/nri3228 · 2012 · External reference
Dysregulation of the epithelial barrier by environmental and other exogenous factors
10.1111/cod.13959 · 2021 · External reference
Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)
10.1016/j.tibtech.2008.11.009 · 2009 · External reference
Platelet-rich plasma: evidence to support its use
10.1016/j.joms.2003.12.003 · 2004 · External reference
Platelet-rich plasma in aesthetic dermatology: current evidence and future directions
10.7759/cureus.66734 · 2024 · External reference
Platelet-Rich plasma (PRP): current applications in dermatology
2019 · External reference
Platelet-rich plasma (PRP) in dermatology: cellular and molecular mechanisms of action
10.3390/biomedicines12010007 · 2023 · External reference
Systematic review of the use of platelet-rich plasma in aesthetic dermatology
10.1111/jocd.12167 · 2015 · External reference
Platelet rich plasma: a short overview of certain bioactive components
10.1515/med-2016-0048 · 2016 · External reference
Platelet alpha-granules: basic biology and clinical correlates
10.1016/j.blre.2009.04.001 · 2009 · External reference
Use of platelet-rich plasma (PRP) and injectable platelet-rich fibrin (i-PRF) in oral lichen planus treatment: a systematic review of randomized controlled trials
10.1186/s12903-025-06189-7 · 2025 · External reference
Platelet-rich plasma: fundamentals and clinical applications
10.1016/j.arthro.2021.07.003 · 2021 · External reference
Use of platelet-rich plasma in rheumatic diseases
10.1007/s00296-024-05776-1 · 2024 · External reference
Variability in platelet-rich plasma preparations used in regenerative medicine: a comparative analysis
10.21203/rs.3.rs-1423315/v1 · 2022 · External reference
Systematic review-the potential implications of different platelet-rich plasma (PRP) concentrations in regenerative medicine for tissue repair
10.3390/ijms21165702 · 2020 · External reference
Current status and advancements in platelet-rich plasma therapy
10.7759/cureus.47176 · 2023 · External reference
Complexity of platelet-rich plasma: mechanism of action, growth factor utilization and variation in preparation
10.1177/26348535241277625 · 2024 · External reference
Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe
10.1111/jdv.18168 · 2022 · External reference
Out-of-pocket costs for individuals with atopic eczema: a cross-sectional study in nine European countries
10.2340/00015555-3102 · 2019 · External reference
Costs of psoriasis in Europe. A systematic review of the literature
10.1016/j.jval.2014.08.2112 · 2014 · External reference
Cost of illness of oral lichen planus: a multicenter university hospital-based outpatient observational study
10.1007/s00784-021-04353-1 · 2022 · External reference
Women and autoimmune diseases
10.3201/eid1011.040367 · 2004 · External reference
Sex differences in dermatology life quality index (DLQI) among patients with psoriasis
10.2340/actadv.v104.42441 · 2024 · External reference
Global skin disease morbidity and mortality: an update from the global burden of disease study 2013
10.1001/jamadermatol.2016.5538 · 2017 · External reference
Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life
10.1038/sj.jid.5701239 · 2008 · External reference
Atopic dermatitis in children
10.3928/19382359-20240205-02 · 2024 · External reference
Gender differences in adult atopic dermatitis and clinical implication: results from a nationwide multicentre study
10.1111/jdv.19580 · 2024 · External reference
Dermatologic health disparities
10.1016/j.det.2011.08.002 · 2012 · External reference
Burden of skin disease and associated socioeconomic status in Europe: an ecologic study from the global burden of disease study 2017
10.1016/j.jdin.2020.07.001 · 2020 · External reference
Socioeconomic status and the prevalence of skin and atopic diseases in five European countries
10.2340/00015555-3082 · 2019 · External reference
Advances in the pathogenesis of psoriasis: from keratinocyte perspective
10.1038/s41419-022-04523-3 · 2022 · External reference
Heterogeneity of inflammatory and cytokine networks in chronic plaque psoriasis
10.1371/journal.pone.0034594 · 2012 · External reference
The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications
10.3390/ijms222312793 · 2021 · External reference
Psoriasis
10.1016/s0140-6736(14)61909-7 · 2015 · External reference
Psoriasis pathogenesis and treatment
10.3390/ijms20061475 · 2019 · External reference
Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences
10.3389/fimmu.2018.00579 · 2018 · External reference
The risk of systemic diseases in those with psoriasis and psoriatic arthritis: from mechanisms to clinic
10.3390/ijms21197041 · 2020 · External reference
Comorbidities associated with psoriatic arthritis: review and update
10.1016/j.clim.2020.108397 · 2020 · External reference
Epidemiology of atopic dermatitis: a global worldwide study
10.1093/ced/llaf233 · 2025 · External reference
Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study
10.1093/bjd/ljad339 · 2023 · External reference
Counting the burden: atopic dermatitis and health-related quality of life
10.2340/00015555-3511 · 2020 · External reference
The burden of atopic dermatitis: summary of a report for the national eczema association
10.1016/j.jid.2016.07.012 · 2017 · External reference
Halting the vicious cycle of atopic dermatitis: empowered by scientific understanding
10.1016/j.jid.2024.03.003 · 2024 · External reference
Comorbidities of atopic dermatitis-what does the evidence say?
10.1016/j.jaci.2022.12.002 · 2023 · External reference
Atopic dermatitis
10.1016/s0140-6736(15)00149-x · 2016 · External reference
The global prevalence of seborrheic dermatitis: a systematic review and meta-analysis
10.1001/jamadermatol.2024.1987 · 2024 · External reference
Nummular eczema and contact allergy: a retrospective study
10.1097/der.0b013e318260d5a0 · 2012 · External reference
Incidence of radiodermatitis and factors associated with its severity in women with breast cancer: a cohort study
10.1016/j.abd.2023.01.004 · 2024 · External reference
Radiation dermatitis: a comparative review of prevention and management
10.1002/der2.70043 · 2025 · External reference
Characterization of skin reactions and pain reported by patients receiving radiation therapy for cancer at different sites
10.12788/j.suponc.0009 · 2013 · External reference
Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis
10.1111/odi.13323 · 2021 · External reference
Prevalence and treatment patterns of lichen planus
10.1016/j.jaad.2024.09.081 · 2025 · External reference
Diagnosis and treatment of lichen planus
2011 · External reference
Rodríguez-de Rivera-Campillo ME, Otero-Rey EM, Estrugo-Devesa A, Jané-Salas E, López-López J. Oral lichen planus and its relationship with systemic diseases. A review of evidence
10.4317/jced.55145 · 2018 · External reference
Lichen sclerosus: the 2023 update
10.3389/fmed.2023.1106318 · 2023 · External reference
Lichen sclerosus and squamous cell carcinoma
10.1016/j.adengl.2011.05.004 · 2012 · External reference
Epidemiology of invasive candidiasis
10.2147/clep.s459600 · 2024 · External reference
Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses
10.1136/sextrans-2024-056307 · 2025 · External reference
Prevalence and species distribution of Candida bloodstream infection in children and adults in two teaching university hospitals in Egypt: first report of Candida kefyr
10.1007/s15010-022-01888-7 · 2023 · External reference
The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma
10.1371/journal.pone.0136789 · 2015 · External reference
Emerging infectious diseases of the skin: a review of clinical and histologic findings
10.1016/j.humpath.2023.07.003 · 2023 · External reference
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management
10.3390/medicina57090895 · 2021 · External reference
Real-world data on severe cutaneous adverse reactions to drugs
10.3390/ph19010021 · 2026 · External reference
Autoimmune bullous diseases: pathogenesis and clinical management
10.1186/s43556-025-00272-9 · 2025 · External reference
The burden of neurological comorbidities in six autoimmune bullous diseases: a population-based study
10.1111/jdv.17465 · 2021 · External reference
Psychosocial burden of autoimmune blistering diseases: a comprehensive survey study
10.1111/jdv.20156 · 2025 · External reference
A narrative review of pemphigoid diseases: bridging associations, comorbidities, and management
10.1007/s13555-025-01444-9 · 2025 · External reference
Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid
10.3389/fimmu.2023.1159351 · 2023 · External reference
The burden of living with cutaneous lupus erythematosus
10.3389/fmed.2022.897987 · 2022 · External reference
Autoimmune diseases in patients with cutaneous lupus erythematosus
10.1001/jamadermatol.2018.0616 · 2018 · External reference
Epidemiology of cutaneous lupus erythematosus among adults over four decades (1976–2018): a lupus midwest network (LUMEN) study
10.1016/j.mayocp.2022.06.022 · 2022 · External reference
Skin and subcutaneous disease burden, 1990–2021: a GBD review
10.1097/js9.0000000000004028 · 2026 · External reference
The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries
10.1038/jid.2014.530 · 2015 · External reference
Shame and disgust in patients with inflammatory skin diseases: a systematic review of psychological correlates and psychotherapeutic approaches
10.3389/fmed.2025.1620940 · 2025 · External reference
Evaluating the psychosocial burden and unmet needs for health care access among older adults with inflammatory skin disease
10.1016/j.jdin.2024.11.006 · 2025 · External reference
The epidemiology of acne in the current era: trends and clinical implications
10.3390/cosmetics12030106 · 2025 · External reference
Incidence and prevalence of rosacea: a systematic review and meta-analysis
10.1111/bjd.16481 · 2018 · External reference
Stigmatization and psychosocial burden in acne patients
10.1111/jocd.16678 · 2025 · External reference
Prevalence of hidradenitis suppurativa: a meta-analysis of global hidradenitis suppurativa atlas studies
10.1001/jamadermatol.2025.2373 · 2025 · External reference
The burden of hidradenitis suppurativa signs and symptoms in quality of life: systematic review and meta-analysis
10.3390/ijerph18136709 · 2021 · External reference
Estimating the burden of vitiligo: a systematic review and modelling study
10.1016/s2468-2667(24)00026-4 · 2024 · External reference
Global burden of alopecia areata from 1990 to 2019 and emerging treatment trends analyzed through GBD 2019 and bibliometric data
10.1038/s41598-025-07224-x · 2025 · External reference
Comorbidity burden among patients with vitiligo in the United States: a large-scale retrospective claims database analysis
10.1007/s13555-023-01001-2 · 2023 · External reference
Comorbid conditions associated with alopecia areata: a systematic review and meta-analysis
10.1007/s40257-023-00805-4 · 2023 · External reference
The JAK-STAT pathway: impact on human disease and therapeutic intervention
10.1146/annurev-med-051113-024537 · 2015 · External reference
TNF-mediated inflammatory disease
10.1002/path.2287 · 2008 · External reference
Overlap between psoriasis and atopic dermatitis: therapeutic approach
10.1016/j.ad.2025.104541 · 2026 · External reference
Janus kinase inhibitors in autoimmune diseases
10.1136/annrheumdis-2012-202576 · 2013 · External reference
The nuclear factor NF-kappaB pathway in inflammation
10.1101/cshperspect.a001651 · 2009 · External reference
Hidradenitis suppurativa: host-microbe and immune pathogenesis underlie important future directions
10.1016/j.xjidi.2021.100001 · 2021 · External reference
Advances in the pathogenesis of rosacea
10.3389/fimmu.2025.1595493 · 2025 · External reference
Updates in pathogenesis of pemphigus vulgaris
10.1111/1346-8138.70077 · 2026 · External reference
Pathogenesis of inflammation in skin disease: from molecular mechanisms to pathology
10.3390/ijms251810152 · 2024 · External reference
Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
10.1016/j.coi.2017.08.008 · 2017 · External reference
Innate immune sensing by epithelial barriers
10.1016/j.coi.2021.07.014 · 2021 · External reference
Pattern recognition receptors and inflammation
10.1016/j.cell.2010.01.022 · 2010 · External reference
Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches
10.3389/fimmu.2024.1361005 · 2024 · External reference
How dying cells alert the immune system to danger
10.1038/nri2215 · 2008 · External reference
Inflammasomes: Threat-assessment organelles of the innate immune system
10.1016/j.immuni.2019.08.005 · 2019 · External reference
Inflammasome, inflammation, and tissue homeostasis
10.1016/j.molmed.2018.01.004 · 2018 · External reference
Type I interferons in infectious disease
10.1038/nri3787 · 2015 · External reference
The IL-17 family in diseases: from bench to bedside
10.1038/s41392-023-01620-3 · 2023 · External reference
Origin and physiological roles of inflammation
10.1038/nature07201 · 2008 · External reference
Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses
10.4049/jimmunol.169.3.1535 · 2002 · External reference
Propionibacterium acnes Induces IL-1β secretion via the NLRP3 inflammasome in human monocytes
10.1038/jid.2013.309 · 2014 · External reference
Inflammatory events are involved in acne lesion initiation
10.1046/j.1523-1747.2003.12321.x · 2003 · External reference
Adaptive and innate immunity in psoriasis and other inflammatory disorders
10.3389/fimmu.2019.01764 · 2019 · External reference
Potential role of innate lymphoid cells in the pathogenesis and treatment of skin diseases
10.3390/jcm12083043 · 2023 · External reference
Gene expression based evidence of innate immune response activation in the epithelium with oral lichen planus
10.1016/j.archoralbio.2013.12.010 · 2014 · External reference
Innate immunity in atopic dermatitis
10.1007/s12016-010-8227-x · 2011 · External reference
T-cell subsets in the skin and their role in inflammatory skin disorders
10.1111/all.15104 · 2022 · External reference
The immunology of psoriasis and biologic immunotherapy
10.1016/s0190-9622(03)01134-4 · 2003 · External reference
Immunopathology and immunotherapy of inflammatory skin diseases
10.4110/in.2022.22.e7 · 2022 · External reference
NF-κB signaling in inflammation
10.1038/sigtrans.2017.23 · 2017 · External reference
The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis
10.4161/jkst.24137 · 2013 · External reference
Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors
10.1002/eji.201646680 · 2017 · External reference
Signalling in inflammatory skin disease by AP-1 (Fos/Jun)
2015 · External reference
Editorial: epithelial immune microenvironment and inflammatory skin diseases
10.3389/fimmu.2024.1428209 · 2024 · External reference
Neuroimmune interactions in chronic itch of atopic dermatitis
10.1111/jdv.15973 · 2020 · External reference
Significance of skin barrier dysfunction in atopic dermatitis
10.4168/aair.2018.10.3.207 · 2018 · External reference
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
10.1016/j.cyto.2014.09.011 · 2015 · External reference
Cytokines in psoriasis
10.1016/j.cyto.2014.12.014 · 2015 · External reference
Cytokine alterations in psoriasis: an updated review
10.1080/1744666x.2022.2011720 · 2021 · External reference
Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis
10.1111/1523-1747.ep12876121 · 1990 · External reference
Dermatitis; types, causes, symptoms and management: a review
10.35702/derm.10016 · 2024 · External reference
Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights
10.1007/s10787-025-01642-z · 2025 · External reference
Restoration of skin barrier abnormalities with IL4/13 inhibitors and jak inhibitors in atopic dermatitis: a systematic review
10.3390/medicina60081376 · 2024 · External reference
Pathogenesis of atopic dermatitis: current paradigm
10.22034/iji.2019.80253 · 2019 · External reference
Filaggrin and beyond: new insights into the skin barrier in atopic dermatitis and allergic diseases, from genetics to therapeutic perspectives
10.1016/j.anai.2023.09.009 · 2024 · External reference
IL-31: a new link between T cells and pruritus in atopic skin inflammation
10.1016/j.jaci.2005.10.033 · 2006 · External reference
Interleukin-31 pathway and its role in atopic dermatitis: a systematic review
10.1080/09546634.2017.1290205 · 2017 · External reference
Reduction of serum interleukin-5 levels reflect clinical improvement in patients with atopic dermatitis
10.1111/j.1346-8138.2001.tb00124.x · 2001 · External reference
Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions
10.4049/jimmunol.178.9.5571 · 2007 · External reference
T-cell adhesion in healthy and inflamed skin
10.1016/j.xjidi.2021.100014 · 2021 · External reference
CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production
10.1371/journal.ppat.1006196 · 2017 · External reference
Targeting the IFN-γ/CXCL10 pathway in lichen planus
10.1016/j.mehy.2016.04.042 · 2016 · External reference
Immune mechanisms in oral lichen planus
10.1111/odi.14142 · 2023 · External reference
Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism
10.1016/s0002-9440(10)63649-8 · 2003 · External reference
Unresolved reference
2026 · External reference
Frontal fibrosing alopecia: an update
10.1007/s40257-024-00912-w · 2025 · External reference
The IFN-γ-CXCL9/CXCL10-CXCR3 axis in vitiligo: pathological mechanism and treatment
10.1002/eji.202250281 · 2024 · External reference
The role of memory CD8(+) T cells in vitiligo
10.4049/jimmunol.1900027 · 2019 · External reference
Vitiligo: from pathogenesis to treatment
10.3390/jcm13175225 · 2024 · External reference
Integrative genetics and multiomics analysis reveal mechanisms and therapeutic targets in vitiligo highlighting JAK STAT pathway regulation of CTSS
10.1038/s41598-025-86134-4 · 2025 · External reference
Unresolved reference
2026 · External reference
Update on cutaneous lupus erythematosus pathogenesis, diagnosis and management
10.1111/jdv.70186 · 2026 · External reference
The genetics of pediatric cutaneous autoimmunity: the sister diseases vitiligo and alopecia areata
10.1016/j.clindermatol.2022.02.009 · 2022 · External reference
Alopecia areata
10.1056/nejmra1103442 · 2012 · External reference
A virtual memory CD8(+) T cell-originated subset causes alopecia areata through innate-like cytotoxicity
10.1038/s41590-023-01547-5 · 2023 · External reference
Alopecia areata: understanding the pathophysiology and advancements in treatment modalities
10.7759/cureus.78298 · 2025 · External reference
Hair follicle immune privilege and its collapse in alopecia areata
10.1111/exd.14155 · 2020 · External reference
Alopecia areata: pathogenesis, diagnosis, and therapies
10.1002/mco2.70182 · 2025 · External reference
Human skin basement membrane in health and in autoimmune diseases
10.2741/a196 · 1997 · External reference
Skin barrier and autoimmunity-mechanisms and novel therapeutic approaches for autoimmune blistering diseases of the skin
10.3389/fimmu.2019.01089 · 2019 · External reference
Pemphigoid diseases
10.1016/s0140-6736(12)61140-4 · 2013 · External reference
An updated review of pemphigus diseases
10.3390/medicina57101080 · 2021 · External reference
Bullous pemphigoid
10.1038/s41572-025-00595-5 · 2025 · External reference
Understanding the role of type I interferons in cutaneous lupus and dermatomyositis: toward better therapeutics
10.1002/art.42983 · 2025 · External reference
Cutaneous lupus erythematosus: diagnosis and treatment. Best practice & research
10.1016/j.berh.2013.07.008 · 2013 · External reference
The spectrum of cutaneous manifestations in lupus erythematosus: a comprehensive review
10.3390/jcm13082419 · 2024 · External reference
Dermatomyositis: clinical features and pathogenesis
10.1016/j.jaad.2019.06.1309 · 2020 · External reference
Morphea (localized scleroderma)
10.1001/jamadermatol.2013.5079 · 2013 · External reference
Small vessel vasculitis of the skin
10.1016/j.rdc.2014.09.006 · 2015 · External reference
Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseases
10.1016/j.coi.2024.102493 · 2024 · External reference
Skin barrier defects in atopic dermatitis: from old idea to new opportunity
10.1016/j.alit.2021.11.006 · 2022 · External reference
Skin barrier function and atopic dermatitis
10.1007/s13671-018-0232-y · 2018 · External reference
Skin barrier dysregulation in psoriasis
10.3390/ijms221910841 · 2021 · External reference
Gene signatures associated with barrier dysfunction and infection in oral lichen planus identified by analysis of transcriptomic data
10.1371/journal.pone.0257356 · 2021 · External reference
Alterations in factors involved in differentiation and barrier function in the epithelium in oral and genital lichen planus
10.2340/00015555-2533 · 2017 · External reference
Hidradenitis suppurativa
10.1016/s0140-6736(24)02475-9 · 2025 · External reference
Interaction between microbiota and immunity in health and disease
10.1038/s41422-020-0332-7 · 2020 · External reference
Dysbiosis in the pathogenesis of atopic dermatitis
10.1111/1346-8138.70191 · 2026 · External reference
Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship
10.1016/j.tim.2017.11.008 · 2018 · External reference
Colonization with staphylococcus aureus in atopic dermatitis patients: attempts to reveal the unknown
10.3389/fmicb.2020.567090 · 2020 · External reference
Psoriasis: microbiome dysbiosis and pathogenic mechanisms
10.3389/fimmu.2026.1714515 · 2026 · External reference
Genital lichen sclerosus-the role of the vulvar microbiome
10.3390/medicina61091632 · 2025 · External reference
Cutaneous dysbiosis in girls with vulvar lichen sclerosus
10.1128/spectrum.02674-24 · 2025 · External reference
Dysbiosis of saliva microbiome in patients with oral lichen planus
10.1186/s12866-020-01733-7 · 2020 · External reference
Role of oral microbiota dysbiosis in the development and progression of oral lichen planus
10.3390/jpm14040386 · 2024 · External reference
The microbiome and acne: perspectives for treatment
10.1007/s13555-023-01079-8 · 2024 · External reference
Oral microbial dysbiosis and pathogenic functional shifts in mucosa-dominant pemphigus vulgaris and low-risk mucous membrane pemphigoid
10.1111/odi.70207 · 2026 · External reference
Cutaneous and gut dysbiosis in alopecia areata: a review
10.1016/j.xjidi.2025.100363 · 2025 · External reference
Association between scalp microbiota imbalance, disease severity, and systemic inflammatory markers in alopecia areata
10.1007/s13555-024-01281-2 · 2024 · External reference
Hidradenitis suppurativa: consequences of microbiome dysbiosis on immune dysregulation and disease severity
10.4103/ijd.ijd_623_21 · 2022 · External reference
Unveiling the microbiome's role in hidradenitis suppurativa: a comprehensive review of pathogenetic mechanisms
10.3390/ijms26199542 · 2025 · External reference
Insights into microbial dysbiosis and Cutibacterium acnes CAMP factor interactions in acne vulgaris
10.1099/mgen.0.001449 · 2025 · External reference
Host responses to Candida albicans: Th17 cells and mucosal candidiasis
10.1016/j.micinf.2010.03.013 · 2010 · External reference
Mucosal bacteria modulate candida albicans virulence in oropharyngeal candidiasis
10.1128/mbio.01937-21 · 2021 · External reference
Itch: from mechanism to (novel) therapeutic approaches
10.1016/j.jaci.2018.09.005 · 2018 · External reference
The immunological anatomy of the skin
10.1038/s41577-018-0084-5 · 2019 · External reference
Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus
10.1038/sj.jid.5700231 · 2006 · External reference
TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes
10.1038/jid.2010.351 · 2011 · External reference
Relationship between transient receptor potential vanilloid-1 expression and the intensity of sensitive skin symptoms
10.1111/jocd.12204 · 2016 · External reference
Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis
10.1016/j.clindermatol.2020.06.016 · 2020 · External reference
Stevens-Johnson syndrome and toxic epidermal necrolysis: an update
10.1007/s40257-015-0158-0 · 2015 · External reference
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): immunologic reactions: oncologic
10.1007/978-3-319-74588-6_195 · 2019 · External reference
The biology of the platelet with special reference to inflammation, wound healing and immunity
10.2741/4613 · 2018 · External reference
Platelets as immune cells: bridging inflammation and cardiovascular disease
10.1161/01.res.0000252802.25497.b7 · 2007 · External reference
Autologous matrix of platelet-rich fibrin in wound care settings: a systematic review of randomized clinical trials
10.3390/jfb11020031 · 2020 · External reference
Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties
10.1902/jop.2007.060302 · 2007 · External reference
Platelets in inflammation and immunity
10.1111/jth.12730 · 2014 · External reference
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages
10.1182/blood.v95.4.1158.004k31_1158_1166 · 2000 · External reference
DAMPening inflammation by modulating TLR signalling
10.1155/2010/672395 · 2010 · External reference
Freedman J. Platelets and the immune continuum
10.1038/nri2956 · 2011 · External reference
Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF
10.1002/jcp.22274 · 2010 · External reference
Platelet-rich plasma for managing pain and inflammation in osteoarthritis
10.1038/nrrheum.2013.141 · 2013 · External reference
Sterile inflammation: sensing and reacting to damage
10.1038/nri2873 · 2010 · External reference
The role of human platelet preparation for toll-like receptors 2 and 4 related platelet responsiveness
10.1055/s-0039-1685495 · 2019 · External reference
Platelet-rich plasma-derived exosomes attenuate intervertebral disc degeneration by promoting NLRP3 autophagic degradation in macrophages
10.1016/j.intimp.2022.108962 · 2022 · External reference
Platelet-conditioned media induces an anti-inflammatory macrophage phenotype through EP4
10.1111/jth.15172 · 2021 · External reference
Anti-inflammation effects of injectable platelet-rich fibrin via macrophages and dendritic cells
10.1002/jbm.a.36792 · 2020 · External reference
Effect of platelet-rich plasma on M1/M2 macrophage polarization
10.3390/ijms22052336 · 2021 · External reference
Platelet-rich plasma-derived exosomes accelerate the healing of diabetic foot ulcers by promoting macrophage polarization toward the M2 phenotype
10.1007/s10238-025-01651-w · 2025 · External reference
10.19746/j.cnki.issn.1009-2137.2023.05.037
10.19746/j.cnki.issn.1009-2137.2023.05.037 · 2023 · External reference
Platelets, after exposure to a high shear stress, induce IL-10-producing, mature dendritic cells in vitro
10.4049/jimmunol.172.9.5297 · 2004 · External reference
Influence of platelet-rich plasma on the immune response of human monocyte-derived dendritic cells and macrophages stimulated with Aspergillus fumigatus
10.1016/j.ijmm.2016.11.010 · 2017 · External reference
Allogeneic platelet-rich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing
10.1002/term.2361 · 2018 · External reference
Platelet-rich plasma relieves inflammation and pain by regulating M1/M2 macrophage polarization in knee osteoarthritis rats
10.1038/s41598-025-97501-6 · 2025 · External reference
Platelet-rich plasma promotes recruitment of macrophages in the process of tendon healing
10.1016/j.reth.2020.03.009 · 2020 · External reference
Immunoregulatory role of platelet derivatives in the macrophage-mediated immune response
10.3389/fimmu.2024.1399130 · 2024 · External reference
Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice
10.1182/bloodadvances.2020002867 · 2020 · External reference
Platelets provoke distinct dynamics of immune responses by differentially regulating CD4+ T-cell proliferation
10.1111/jth.12612 · 2014 · External reference
Platelet-rich plasma (PRP): molecular mechanisms, actions and clinical applications in human body
10.3390/ijms262110804 · 2025 · External reference
Characterization of autologous platelet rich plasma (PRP) and its biological effects in patients with Behçet's Disease
10.1016/j.reth.2021.08.010 · 2021 · External reference
Platelet-derived GARP induces peripheral regulatory T cells-potential impact on T cell suppression in patients with melanoma-associated thrombocytosis
10.3390/cancers12123653 · 2020 · External reference
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
10.1182/blood-2010-04-281717 · 2010 · External reference
Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy
10.1186/s40364-024-00700-y · 2024 · External reference
Fresh evidence for platelets as neuronal and innate immune cells: their role in the activation, differentiation, and deactivation of Th1, Th17, and tregs during tissue inflammation
10.3389/fimmu.2018.00406 · 2018 · External reference
The role of platelets in immune-mediated inflammatory diseases
10.1038/s41577-023-00834-4 · 2023 · External reference
Efficacy of platelet-rich plasma therapy in oral lichen planus: a systematic review
10.3390/medicina59040746 · 2023 · External reference
Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
10.3389/fimmu.2025.1692916 · 2025 · External reference
Platelet-rich plasma for the treatment of plaque psoriasis: a systematic review
10.7759/cureus.50356 · 2023 · External reference
Lagrán Z, Alkhraisat MH. Bioactive effect of plasma-rich in growth factors (PRGFs) on cell-based in vitro models of skin inflammation in relation to inflammatory skin disorders
10.7759/cureus.74252 · 2024 · External reference
Platelet lysate induces in vitro wound healing of human keratinocytes associated with a strong proinflammatory response
10.1089/ten.tea.2010.0729 · 2011 · External reference
Platelet-rich plasma contributes to chondroprotection by repairing mitochondrial function via AMPK/NF-κB signaling in osteoarthritic chondrocytes
10.1016/j.tice.2022.101830 · 2022 · External reference
del Olmo-Aguado S, García-Pérez E, Fernández-Vega-Cueto L, Fernández-Vega Cueto A, Baamonde-Arbaiza B, et al. Plasma rich in growth factors promotes autophagy in ARPE19 cells in response to oxidative stress induced by blue light
10.3390/biom11070954 · 2021 · External reference
Platelet-rich plasma-derived extracellular vesicles inhibit NF-κB/NLRP3 pathway-mediated pyroptosis in intervertebral disc degeneration via the MALAT1/microRNA-217/SIRT1 axis
10.1016/j.cellsig.2024.111106 · 2024 · External reference
Advances in platelet rich plasma-derived extracellular vesicles for regenerative medicine: a systematic-narrative review
10.3390/ijms241713043 · 2023 · External reference
Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes
10.1177/0363546511419278 · 2011 · External reference
Biology of platelet-rich plasma and its clinical application in cartilage repair
10.1186/ar4493 · 2014 · External reference
IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway
10.1371/journal.pone.0028663 · 2011 · External reference
Mechanism of platelet-rich plasma in promoting diabetic wound healing via the PI3K/AKT signaling pathway to regulate collagen synthesis and angiogenesis
10.1155/jdr/1254597 · 2026 · External reference
In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis
10.1038/s41598-021-90174-x · 2021 · External reference
TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers
10.1038/onc.2012.171 · 2013 · External reference
microRNAs are abundant and stable in platelet-rich fibrin and other autologous blood products of canines
10.3390/ijms24010770 · 2023 · External reference
Platelets rich plasma increases antioxidant defenses of tenocytes via Nrf2 signal pathway
10.3390/ijms241713299 · 2023 · External reference
Platelet-released growth factors (PRGFs) activate NRF2-ARE and modulate inflammatory response in an nrf2-dependent manner in primary human keratinocytes
10.1111/jocd.70228 · 2025 · External reference
Platelet rich plasma and adipose-derived mesenchymal stem cells mitigate methotrexate-induced nephrotoxicity in rat via Nrf2/Pparγ/HO-1 and NF-?
10.3390/toxics11050398 · 2023 · External reference
Platelet-rich plasma and IL-1β antagonist receptor peptide attenuate the inflammatory process of muscle injury in wistar rats
10.1038/s41598-025-98998-7 · 2025 · External reference
Wnt5a/Platelet-rich plasma synergistically inhibits IL-1β-induced inflammatory activity through NF-κB signaling pathway and prevents cartilage damage and promotes meniscus regeneration
10.1002/term.3198 · 2021 · External reference
Platelet-rich plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes
10.1007/s11999-015-4179-z · 2015 · External reference
Effect of two different preparations of platelet-rich plasma on synoviocytes
10.1007/s00167-014-3113-3 · 2015 · External reference
The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis
10.1177/0363546513507766 · 2014 · External reference
Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-α and IL-1
10.1002/jor.22532 · 2014 · External reference
Pure platelet-rich plasma and supernatant of calcium-activated P-PRP induce different phenotypes of human macrophages
10.2217/rme-2017-0122 · 2018 · External reference
Activated platelets induce an anti-inflammatory response of monocytes/macrophages through cross-regulation of PGE and cytokines
10.1155/2017/1463216 · 2017 · External reference
Activated platelets enhance IL-10 secretion and reduce TNF-α secretion by monocytes
10.4049/jimmunol.1201103 · 2013 · External reference
Platelet-rich plasma improves lipopolysaccharide-induced inflammatory response by upgrading autophagy
10.1177/1721727x221112271 · 2022 · External reference
Platelet-rich plasma in peripheral nerve injury repair: a comprehensive review of mechanisms, clinical applications, and therapeutic potential
10.3389/ebm.2025.10746 · 2025 · External reference
Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution
10.1089/ten.tea.2012.0225 · 2013 · External reference
Comparative evaluation of the effects of platelet-rich plasma formulations on extracellular matrix formation and the NF-κB signaling pathway in human articular chondrocytes
10.3892/mmr.2017.6365 · 2017 · External reference
Elevated IL-1β and comparable IL-1 receptor antagonist levels are characteristic features of L-PRP in female college athletes compared to male professional soccer players
10.3390/ijms242417487 · 2023 · External reference
The role of platelet-rich plasma in tissue regeneration
10.3109/09537104.2012.684730 · 2013 · External reference
Action of platelet-rich plasma on in vitro cellular bioactivity: more than platelets
10.3390/ijms24065367 · 2023 · External reference
Autologous platelets as a source of proteins for healing and tissue regeneration
10.1160/th03-07-0440 · 2004 · External reference
Platelet-rich plasma (PRP) and recombinant growth factor therapies in cutaneous wound healing: mechanisms, clinical applications, and future directions
10.3390/jcm14238583 · 2025 · External reference
Skin fibrosis: models and mechanisms
10.1016/j.retram.2016.06.003 · 2016 · External reference
Wound repair and regeneration
10.1038/nature07039 · 2008 · External reference
The role of TGF-β1/Smad2/3 pathway in platelet-rich plasma in retarding intervertebral disc degeneration
10.1111/jcmm.12847 · 2016 · External reference
Platelet-rich plasma respectively reduces and promotes adipogenic and myofibroblastic differentiation of human adipose-derived stromal cells via the TGFβ signalling pathway
10.1038/s41598-017-03113-0 · 2017 · External reference
Platelet-rich plasma prolongs myofibroblast accumulation in corneal stroma with incisional wound
10.3109/02713683.2014.978478 · 2015 · External reference
Induction and maintenance of regulatory T cells by transcription factors and epigenetic modifications
10.1016/j.jaut.2017.07.002 · 2017 · External reference
Molecular mechanisms regulating TGF-β-induced Foxp3 expression
10.1038/mi.2010.7 · 2010 · External reference
Platelet-rich plasma attenuates the severity of joint capsule fibrosis following post-traumatic joint contracture in rats
10.3389/fbioe.2022.1078527 · 2022 · External reference
Platelet-rich plasma promotes the regeneration of cartilage engineered by mesenchymal stem cells and collagen hydrogel via the TGF-β/SMAD signaling pathway
10.1002/jcp.28211 · 2019 · External reference
Injectable platelet-rich fibrin promotes proliferation and trichogenic inductivity of dermal papilla cells through activating TGF-β/Smad signaling pathway
10.14715/cmb/2024.70.4.25 · 2024 · External reference
Autologous fat granules combined with PRP treat hypertrophic scars through TGF-β/Smad signaling pathway
10.1007/s00266-025-05136-9 · 2025 · External reference
Platelet-rich plasma (PRP) bidirectionally modulates scar formation via the Piezo1-YAP/TAZ axis: a novel mechanotransduction hypothesis
10.3389/fcell.2026.1734266 · 2026 · External reference
Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair
10.1073/pnas.0306068101 · 2004 · External reference
Epidermal growth factor and epidermal growth factor receptor: the yin and yang in the treatment of cutaneous wounds and cancer
10.1089/wound.2011.0326 · 2013 · External reference
Regulation of wound healing by growth factors and cytokines
10.1152/physrev.2003.83.3.835 · 2003 · External reference
Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles
10.1182/blood-2013-03-492801 · 2013 · External reference
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
10.1038/s41580-020-0230-3 · 2020 · External reference
Platelet-rich plasma may accelerate diabetic wound healing by modulating epithelial/endothelial-mesenchymal transition through inhibiting reactive oxygen species-mediated oxidative stress
10.3389/fbioe.2025.1623780 · 2025 · External reference
Leucocyte-rich platelet-rich plasma enhances fibroblast and extracellular matrix activity: implications in wound healing
10.3390/ijms21186519 · 2020 · External reference
Angiogenesis and tissue repair depend on platelet dosing and bioformulation strategies following orthobiological platelet-rich plasma procedures: a narrative review
10.20944/preprints202306.0745.v1 · 2023 · External reference
Platelet rich plasma extract promotes angiogenesis through the angiopoietin1-Tie2 pathway
10.1016/j.mvr.2013.04.008 · 2013 · External reference
Increased expression of angiopoietin 2 and Tie2 in Rosacea
10.3390/dermatopathology13010002 · 2025 · External reference
Effect of platelet-rich plasma versus platelet lysate on imiquimod-induced psoriasis-like skin inflammation in adult male albino rat model: a histological, immunohistochemical, and ultrastructural study
10.1093/mam/ozag017 · 2026 · External reference
Platelet-derived extracellular vesicles alleviate psoriatic inflammation via mitochondrial transfer to macrophages
10.1111/exd.70152 · 2025 · External reference
Platelet-rich plasma activates AKT signaling to promote wound healing in a mouse model of radiation-induced skin injury
10.1186/s12967-019-2044-7 · 2019 · External reference
Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization
10.1093/burnst/tkaa028 · 2020 · External reference
How to explain the beneficial effects of platelet-rich plasma
10.1111/prd.12565 · 2000 · External reference
Growth factors and cytokines in wound healing
10.1111/j.1524-475x.2008.00410.x · 2008 · External reference
Regenerative potential of platelet concentrates in chronic oral mucosal lesions
10.1016/j.jobcr.2024.02.007 · 2024 · External reference
The skin barrier: epidermis vs. environment
10.1111/exd.13731 · 2018 · External reference
Platelet-rich plasma in dermatology: new insights on the cellular mechanism of skin repair and regeneration
10.3390/life14010040 · 2023 · External reference
Platelet-released growth factors induce differentiation of primary keratinocytes
10.1155/2017/5671615 · 2017 · External reference
Platelet derivatives and the immunomodulation of wound healing
10.3390/ijms23158370 · 2022 · External reference
Microbiota in health and diseases
10.1038/s41392-022-00974-4 · 2022 · External reference
Skin deep: the role of the microbiota in cutaneous autoimmunity
10.1016/j.jid.2021.12.005 · 2022 · External reference
Microbiota and immune-mediated skin diseases-an overview
10.3390/microorganisms7090279 · 2019 · External reference
Host-microbiota interactions in immune-mediated diseases
10.1038/s41579-020-0367-2 · 2020 · External reference
The skin: an indispensable barrier
10.1111/j.1600-0625.2008.00786.x · 2008 · External reference
Characterization of distinct microbiota associated with androgenetic alopecia patients treated and untreated with platelet-rich plasma (PRP)
10.1002/ame2.12414 · 2024 · External reference
Antimicrobial effects of platelet-rich plasma and platelet-rich fibrin: a scoping review
10.7759/cureus.51360 · 2023 · External reference
In vitro antibacterial activity of platelet-rich plasma against gram-positive and gram-negative pathogens
10.3389/fcimb.2026.1757780 · 2026 · External reference
PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP
10.3791/50351 · 2013 · External reference
Platelet-rich plasma as a potential antimicrobial agent against multidrug-resistant bacteria in diabetic foot infections
10.1038/s41598-025-97418-0 · 2025 · External reference
Platelet-rich plasma for the treatment of tissue infection: preparation and clinical evaluation
10.1089/ten.teb.2018.0309 · 2019 · External reference
Systematic literature review evaluating evidence and mechanisms of action for platelet-rich plasma as an antibacterial agent
10.1186/s13019-021-01652-2 · 2021 · External reference
Antibacterial and antibiofilm activity of platelet-rich plasma under different activation conditions against multidrug-resistant MRSA isolated from human skin abscesses
10.1186/s12896-025-01078-x · 2025 · External reference
Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infection
10.1002/adhm.201200465 · 2013 · External reference
An experimental study on antimicrobial efficacy of platelet-rich plasma for bone infection prophylaxis
2010 · External reference
Effectiveness of platelet-rich plasma injections as prophylaxis for recurrent urinary tract infection in women
10.3390/jcm12124129 · 2023 · External reference
Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity
10.1186/1471-2180-13-47 · 2013 · External reference
In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood
10.11138/mltj/2014.4.1.079 · 2014 · External reference
Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study
10.1007/s00068-018-0957-0 · 2019 · External reference
An evaluation of the bacteriostatic effect of platelet-rich plasma
10.1111/iwj.13545 · 2021 · External reference
Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds
10.2147/idr.s186651 · 2019 · External reference
Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study
10.1302/0301-620x.89b3.18491 · 2007 · External reference
Leukocyte presence does not increase microbicidal activity of platelet-rich plasma in vitro
10.1186/s12866-015-0482-9 · 2015 · External reference
Antibacterial activity of leukocyte- and platelet-rich plasma: an in vitro study
10.1155/2018/9471723 · 2018 · External reference
Efficacy of topical platelet-rich plasma and chitosan co-administration on Candida albicans-infected partial thickness burn wound healing
10.1016/j.burns.2020.05.019 · 2020 · External reference
Effectiveness of topical administration of platelet-rich plasma on the healing of methicillin-resistant Staphylococcus aureus-infected full-thickness wound model
10.1016/j.bjps.2022.11.059 · 2023 · External reference
Psoriasis: an update on topical and systemic therapies
10.18773/austprescr.2025.026 · 2025 · External reference
Psoriasis: epidemiology, clinical features, and quality of life
10.1136/ard.2004.033217 · 2005 · External reference
Focused update: guidelines of care for the management of atopic dermatitis in adults
10.1016/j.jaad.2025.05.1386 · 2025 · External reference
Management of atopic dermatitis: a narrative review
10.5694/mja2.51560 · 2022 · External reference
Biologics and small molecule inhibitors: an update in therapies for allergic and immunologic skin diseases
10.1007/s11882-022-01047-w · 2022 · External reference
Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review
10.1007/s00403-018-1808-x · 2018 · External reference
Long-term effectiveness and reasons for discontinuation of dupilumab in patients with atopic dermatitis
10.1001/jamadermatol.2024.2517 · 2024 · External reference
Biologics to treat atopic dermatitis: effectiveness, safety, and future directions
10.1111/all.70061 · 2026 · External reference
Deciding which patients with atopic dermatitis to prioritize for biologics and janus kinase inhibitors
10.1016/j.jaip.2025.04.042 · 2025 · External reference
Mechanisms underlying lichen planus in association with biologic therapy
10.2147/jir.s554375 · 2025 · External reference
Unresolved reference
2021 · External reference
Biologic therapy for autoimmune diseases: an update
10.1186/1741-7015-11-88 · 2013 · External reference
US health care disparities in immunology biologics access: a systematic review
10.37765/ajmc.2025.89774 · 2025 · External reference
Interleukin 17 expression in psoriatic skin lesions before and after treatment with platelet rich plasma (PrP)
10.21608/mjcu.2018.56346 · 2018 · External reference
Can platelet-rich plasma reduce the burden of inflammatory skin diseases such as psoriasis and atopic dermatitis?
10.7759/cureus.18472 · 2021 · External reference
Clinical efficacy of platelet rich plasma in combination with methotrexate in chronic plaque psoriatic patients
10.1111/dth.12388 · 2016 · External reference
Evaluation of platelet rich plasma in the management of psoriasis
10.21608/bjas.2018.179330 · 2018 · External reference
Efficacy of intralesional injection of platlet rich plasma in combination with methoterexate in chronic plaque psoriasis
10.66344/jpad.v32i2.1854 · 2022 · External reference
Platelet-rich plasma use in the treatment of eczema (Atopic dermatitis): case report
2018 · External reference
The efficacy and safety of autologous activated platelet-rich plasma therapy as adjuvant treatment of atopic dermatitis in pregnant woman
10.17532/jhsci.2023.2178 · 2023 · External reference
Long-term control of atopic dermatitis with platelet-rich plasma
10.1016/j.jdcr.2020.10.036 · 2021 · External reference
An autologous topical serum derived from platelet-rich plasma therapy for the management of sensitive skin alterations: a case series report
10.2147/ccid.s379323 · 2022 · External reference
Possible clinical efficacy and tolerability of platelet-rich plasma with atopic dermatitis
10.1111/jocd.14170 · 2021 · External reference
Excellent response with platelet-rich plasma treatment in a case of steroid-induced rosacea-like dermatitis
10.1111/jocd.14469 · 2022 · External reference
Resultados del plasma rico en plaquetas como tratamiento coadyuvante en la dermatitis seborreica en una clínica privada. Asunción, 2024
2025 · External reference
Autologous platelet-rich gel versus vitamin B12 for the treatment of grade III-IV acute radiation dermatitis in malignant tumor patients undergoing radiotherapy: an open-label randomized controlled clinical trial
10.3389/fonc.2025.1576458 · 2025 · External reference
Xenogeneic platelet-rich plasma lotion for preventing acute radiation dermatitis in patients with breast cancer undergoing radiotherapy: An open-label, randomized controlled trial
10.1016/j.jpra.2024.11.017 · 2025 · External reference
Severe skin radiodermatitis fully healed with the use of platelet gel and a hyperbaric chamber
2016 · External reference
Homologous platelet gel on radiation-induced dermatitis in a patient receiving head and neck radiotherapy plus cetuximab: a case report
10.1097/md.0000000000034779 · 2023 · External reference
Platelet gel in cutaneous radiation dermatitis
10.1007/s00520-012-1635-0 · 2013 · External reference
Platelet-rich concentrates in the management of lichen planus—a comprehensive review
10.3390/jcm14155368 · 2025 · External reference
kamarthi N, Sumit G, Sangeeta M, Swati G, Abhinav S. Comparative evaluation of autologous platelet rich plasma and triamcinolone acetonide injection in the management of erosive lichen planus and oral submucous fibrosis: a clinical study
10.18203/2319-2003.ijbcp20231125 · 2023 · External reference
Comparative evaluation of effectiveness of autologous platelet rich plasma and intralesional corticosteroids in the management of erosive oral Lichen planus- a clinical study
10.1016/j.jobcr.2020.09.008 · 2020 · External reference
Efficacy of injectable platelet-rich fibrin in the erosive oral lichen planus: a split-mouth, randomized, controlled clinical trial
10.1590/1678-7757-2021-0180 · 2021 · External reference
Efficacy of injectable platelet-rich fibrin in the treatment of symptomatic oral lichen planus
10.1111/odi.14261 · 2023 · External reference
Efficacy of intralesional injections of platelet-rich plasma in patients with oral lichen planus: a pilot randomized clinical trial
10.1002/cre2.550 · 2022 · External reference
Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study
10.1007/s00784-020-03702-w · 2021 · External reference
Comparative evaluation of intralesional injection of autologous platelet rich plasma versus intralesional injection of corticosteroids in the management of resistant oral lichen planus
10.37506/ijocd.v11i2.20053 · 2023 · External reference
Mucoadhesive mycophenolate mofetil and injectable platelet rich fibrin in the treatment of oral lichen planus
10.4103/tdj.tdj_34_24 · 2024 · External reference
Efficacy and safety of platelet lysate mucoadhesive gel in the treatment of patients suffering from an erosive form of oral lichen planus: a randomized placebo-controlled clinical trial
10.21608/edj.2022.146525.2166 · 2022 · External reference
Intralesional injection of platelet-rich plasma versus steroid in the treatment of oral lichen planus
10.1111/jocd.15622 · 2023 · External reference
Platelet-rich plasma (PRP) rinses for the treatment of non-responding oral lichen planus: a case report
10.3390/biomedicines6010015 · 2018 · External reference
Platelet rich plasma a new prospective in treatment of recalcitrant erosive lichen planus–a case report
2020 · External reference
Clinical evaluation of the efficiency of intralesional injection of autologous platelet rich plasma in treatment of erosive oral lichen planus
10.21608/edj.2021.51346.1366 · 2021 · External reference
Effects of intralesional platelets-rich plasma injections on oral lichen planus lesions and salivary interleukin-8
10.4103/mjbl.mjbl_359_22 · 2023 · External reference
Oral lichen planus: therapy and phenotype
10.23736/s0392-0488.16.05399-2 · 2016 · External reference
The role of platelet rich plasma injection in the treatment of oral lichen planus patients
2023 · External reference
Oral lichen planus treated with plasma rich in growth factors
10.12788/cutis.0468 · 2022 · External reference
Biomolecules in the treatment of lichen planus refractory to corticosteroid therapy: clinical and histopathological assessment
10.1016/j.aanat.2017.12.006 · 2018 · External reference
Biological therapy of refractory ulcerative oral lichen planus with plasma rich in growth factors
10.1007/s40257-017-0277-x · 2017 · External reference
Effectiveness of platelet-rich plasma gel alongside tacrolimus ointment in managing erosive oral lichen planus and its effect on oral immune microenvironment
10.36721/pjps.2024.37.6.reg.1625-1633.1 · 2024 · External reference
The efficacy of platelet-rich plasma in facial lichen planus pigmentosus: a prospective pilot study
10.1002/hsr2.70455 · 2025 · External reference
Platelet-rich plasma as a novel treatment for lichen planopillaris
10.1111/dth.12343 · 2016 · External reference
Use of platelet-rich plasma in lichen planopilaris and its variants: a retrospective case series demonstrating treatment tolerability without koebnerization
10.1016/j.jaad.2020.06.026 · 2020 · External reference
Platelet-rich plasma as an adjunctive treatment in lichen planopilaris
10.1016/j.jaad.2018.09.013 · 2019 · External reference
Hair transplantation for lichen planopilaris: a case series of five patients
10.3390/jcm14176199 · 2025 · External reference
Successful hair transplant outcome in cicatricial lichen planus of the scalp by combining scalp and beard hair along with platelet rich plasma
10.4103/0974-2077.178562 · 2016 · External reference
Platelet-rich plasma as a new and successful treatment for lichen planopilaris: a controlled blinded randomized clinical trial
10.1111/jocd.16302 · 2024 · External reference
Platelet-rich plasma for treatment resistant frontal fibrosing alopecia: a case report
10.1111/dth.13072 · 2019 · External reference
Plasma rich in growth factors as an adjuvant treatment for the management of frontal fibrosing alopecia: a retrospective observational clinical study
10.1177/12034754231177599 · 2023 · External reference
A randomized double-blind placebo-controlled trial of autologous platelet-rich plasma intradermal injections for the treatment of vulvar lichen sclerosus
10.1016/j.jaad.2018.12.060 · 2019 · External reference
The effect of lipofilling and platelet-rich plasma on patients with moderate-severe vulvar lichen sclerosus who were non-responders to topical clobetasol propionate: a randomized pilot study
10.1007/s00266-021-02718-1 · 2022 · External reference
Autologous platelet-rich plasma (PRP) in chronic penile lichen sclerosus: the impact on tissue repair and patient quality of life
10.1007/s11255-017-1523-0 · 2017 · External reference
Use of platelet-rich plasma for vulvovaginal autoimmune conditions like lichen sclerosus
10.1097/gox.0000000000001124 · 2016 · External reference
Intradermal injection of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus
10.1016/j.jaad.2016.07.037 · 2017 · External reference
Platelet-rich plasma for male genital lichen sclerosus resistant to conventional therapy: first prospective study
10.1111/dth.14032 · 2020 · External reference
First use of cord blood platelet-rich plasma in the treatment of vulvar lichen sclerosus: a preliminary study towards a randomized controlled trial
10.2450/bloodtransfus.875 · 2025 · External reference
Is there a role for platelet rich plasma injection in vulvar lichen sclerosus? A self-controlled pilot study
10.1007/s00404-024-07424-2 · 2024 · External reference
Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP?
10.1080/09546634.2020.1854650 · 2022 · External reference
The use of PRP (platelet-rich plasma) in patients affected by genital lichen sclerosus: clinical analysis and results
10.1111/jdv.15190 · 2019 · External reference
Usefulness of video thermography in the evaluation of platelet-rich plasma effectiveness in vulvar lichen sclerosus: preliminary study
10.1080/09546634.2019.1685644 · 2021 · External reference
de la Cruz Cea L, Oreja Cuesta AB. Mid-term symptomatic relief after platelet-rich plasma infiltration in vulvar lichen sclerosus
10.1007/s00403-023-02529-1 · 2023 · External reference
Evaluating in office surgery followed by platelet rich plasma to treat lichen sclerosus
10.1097/lgt.0000000000000491 · 2019 · External reference
Management of lichen sclerosus and related comorbidities at a tertiary referral center: beyond topical steroids
10.5826/dpc.1404a262 · 2024 · External reference
Platelet-rich plasma (PRP) for the treatment of vulvar lichen sclerosus in a premenopausal woman: a case report
10.1016/j.crwh.2018.e00062 · 2018 · External reference
Regenerative therapies in lichen sclerosus genitalis patients and possible efficacy in preventing squamous cell carcinoma development: a long-term follow-up pilot study
10.4081/dr.2024.10079 · 2025 · External reference
Adipose tissue stromal vascular fraction and adipose tissue stromal vascular fraction plus platelet-rich plasma grafting: new regenerative perspectives in genital lichen sclerosus
10.1111/dth.14277 · 2020 · External reference
Efficacy and safety of combined platelet-rich plasma with fractional laser for adult patients with vitiligo: a systematic review and meta-analysis of randomized controlled trials
10.1111/jocd.70245 · 2025 · External reference
The use of platelet-rich plasma in wound healing and vitiligo: a systematic review and meta-analysis
10.1111/srt.13444 · 2023 · External reference
Triple combination of fractional carbon dioxide laser, 308-nm excimer lamp, and platelet-rich plasma in refractory vitiligo: a randomized split-body comparative study
10.25259/jcas_16_2024 · 2025 · External reference
A systematic review of case series and clinical trials investigating regenerative medicine for the treatment of vitiligo
10.1111/jocd.16660 · 2025 · External reference
Current art of combination therapy with autologous platelet-rich plasma for stable vitiligo: a meta-analysis
10.1111/iwj.13524 · 2021 · External reference
Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo
10.1177/03000605221119646 · 2022 · External reference
A triple combination of latanoprost, fractional CO laser, and platelet-rich plasma in localized vitiligo: a clinical and histopathologic study
10.1111/phpp.12944 · 2024 · External reference
The usefulness of platelet-rich plasma (PRP) for the treatment of vitiligo: state of the art and review
10.2147/dddt.s239912 · 2020 · External reference
Effect of platelet-rich plasma in refractory vitiligo by promoting the differentiation of dermal melanocyte progenitors via IGFBP-2/RhoA/YAP pathway
10.1016/j.jare.2026.02.057 · 2026 · External reference
The value of adding platelet-rich plasma (PRP) to noncultured epidermal cell suspension (NCECS) in surgical treatment of stable resistant vitiligo: a self-controlled randomised double-blinded study
10.1111/ajd.14080 · 2023 · External reference
Pilot study on the use of the “Monocyte-Rich” platelet-rich plasma in combination with 1927 nm fractional and 308 nm excimer lasers for the treatment of vitiligo
10.3390/medicina57090904 · 2021 · External reference
Platelet-rich plasma, a promising adjunctive treatment for vitiligo: a case report
10.1016/j.jdcr.2020.09.021 · 2020 · External reference
Effect of platelet-rich plasma on the outcome of mini-punch grafting procedure in localized stable vitiligo: clinical evaluation and relation to lesional basic fibroblast growth factor
10.1111/dth.14738 · 2021 · External reference
Efficacy of autologous platelet-rich plasma in the treatment of vitiligo: a 10-patient prospective study
10.1111/jocd.15050 · 2022 · External reference
The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study
10.1111/jocd.12194 · 2016 · External reference
Platelet-rich plasma in the management of alopecia: a systematic review and meta-analysis of clinical evidence
10.1007/s13555-025-01542-8 · 2025 · External reference
Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: a systematic review
10.3389/fmed.2022.1058431 · 2022 · External reference
Platelet rich plasma and its use in hair regrowth: a review
10.2147/dddt.s356858 · 2022 · External reference
Platelet-rich plasma for the treatment of alopecia: a systematic review and meta-analysis
10.2450/2021.0216-2 · 2023 · External reference
Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata
10.1080/09546634.2018.1544405 · 2019 · External reference
An overview of the biology of platelet-rich plasma and microneedling as potential treatments for alopecia areata
10.1016/j.jisp.2017.10.002 · 2018 · External reference
Evaluation of platelet-rich plasma on hair regrowth and lesional T-cell cytokine expression in alopecia areata: a randomized observer-blinded, placebo-controlled, split-head pilot study
10.1016/j.jaad.2020.12.039 · 2021 · External reference
Intralesional triamcinolone acetonide versus platelet rich plasma: a comparative study in the treatment of alopecia areata of scalp
10.18203/issn.2455-4529.intjresdermatol20193223 · 2019 · External reference
Comparative evaluation of therapeutic efficacy of intralesional injection of triamcinolone acetonide versus intralesional autologous platelet-rich plasma injection in alopecia areata
10.4103/jcas.jcas_16_19 · 2020 · External reference
Intralesional platelet-rich plasma injection in patients with recalcitrant alopecia areata
10.14744/semb.2025.63444 · 2025 · External reference
Platelet-rich plasma in alopecia areata: intradermal injection versus topical application with transepidermal delivery via either fractional carbon dioxide laser or microneedling
10.15570/actaapa.2020.35 · 2020 · External reference
Alopecia areata treated with advanced platelet-rich fibrin using micronization
10.1097/gox.0000000000004032 · 2022 · External reference
Platelet-rich plasma in alopecia areata: a case report with a mini review of literature
10.7759/cureus.38751 · 2023 · External reference
Growth factors and microneedling in alopecia areata: a narrative review
10.1159/000534636 · 2024 · External reference
Role of platelet-rich plasma in chronic alopecia areata: our centre experience
10.4103/0970-0358.155271 · 2015 · External reference
The role of platelet-rich plasma therapy in refractory folliculitis decalvans
10.1016/j.jdcr.2021.04.008 · 2021 · External reference
Platelet-rich plasma and acellular dermal matrix in the surgical treatment of hidradenitis suppurativa: a comparative retrospective study
10.3390/jcm12062112 · 2023 · External reference
Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix
10.1111/iwj.12117 · 2015 · External reference
Accelerated wound healing after wide excisions in hidradenitis suppurativa using autologous split-thickness skin grafting and platelet-rich plasma
10.1111/iwj.12673 · 2017 · External reference
Mini skin graft and platelet-rich fibrin combination following hidradenitis suppurativa surgery: a pediatric case report
10.1111/pde.15979 · 2025 · External reference
Hidradenitis suppurativa and wound management
10.1177/1534734615598890 · 2015 · External reference
Platelet rich plasma use for treatment of acne scars: an overview of systematic reviews
10.2450/bloodtransfus.536 · 2024 · External reference
Clinical evaluation of efficacy of intralesional platelet-rich plasma injection versus 1064 nm long-pulsed Neodymium: YAG laser in the treatment of inflammatory acne vulgaris in adolescent and post-adolescent patients: a prospective randomized split-face comparative study
10.1007/s10103-022-03510-6 · 2022 · External reference
Fluid platelet-rich fibrin (PRF) versus platelet-rich plasma (PRP) in the treatment of atrophic acne scars: a comparative study
10.1007/s00403-022-02511-3 · 2023 · External reference
Platelet rich plasma injection versus topical erythromycin 2% in treatment of acne vulgaris
10.1080/09546634.2020.1793884 · 2022 · External reference
Comparing the efficacy of intra-dermal platelet rich plasma (PRP) versus 50% trichloracetic acid (TCA) using cross technique for atrophic acne scars
10.29271/jcpsp.2021.01.55 · 2021 · External reference
Combined effect of microneedling and platelet-rich plasma for the treatment of acne scars: a meta-analysis
10.3389/fmed.2021.788754 · 2021 · External reference
Microneedling with PRP for acne scars: a new tool in dermatologist arsenal - a scoping review
10.4103/jpbs.jpbs_804_23 · 2024 · External reference
Ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma in the treatment of atrophic acne scars: a systematic review and meta-analysis
10.1111/dth.15888 · 2022 · External reference
Platelet-rich plasma as an adjuvant therapy to fractional ablative carbon dioxide lasers for cutaneous repair: a complementary treatment for atrophic acne scarring
10.1007/s10103-024-04192-y · 2024 · External reference
Evaluation of the efficacy, safety, and satisfaction rates of platelet-rich plasma, non-cross-linked hyaluronic acid, and their combination in patients with acne scars treated with fractional CO laser: a randomized, double-blind, split-face comparative study
10.1007/s00266-025-05359-w · 2026 · External reference
Therapeutic efficacy of a plasma rich in growth factors gel combined with fractional ablative laser in the management of post-acne scars
10.4103/jcas.jcas_160_21 · 2022 · External reference
Platelet-rich plasma in the treatment of scars, to suggest or not to suggest? A systematic review and meta-analysis
10.1002/term.3338 · 2022 · External reference
Evaluation of the efficacy and safety of platelet rich plasma injection in treatment of rosacea
10.1111/dth.15049 · 2021 · External reference
Improvement of rosacea by injection of platelet-rich plasma
10.25056/jcm.2019.3.2.125 · 2019 · External reference
Successful treatment of complex and refractory rosacea using platelet-rich plasma injection therapy: case series and review of the literature
10.1111/jocd.70031 · 2025 · External reference
Efficacy and safety of pulsed radiofrequency combined with platelet-rich plasma in the treatment of postherpetic neuralgia: a systematic review and meta-analysis
10.2147/jpr.s548797 · 2025 · External reference
The effects of platelet-rich plasma on zoster-associated pain: a scoping review
10.1186/s12871-025-03426-y · 2025 · External reference
The use of biostatic human amnion and platelet-rich plasma in topical treatment of toxic epidermal necrolysis-a case report
10.1111/jocd.13864 · 2021 · External reference
Adult-onset linear morphea (en coupe de sabre) of the face successfully treated with photoactivated low-temperature platelet-rich plasma: a valid therapeutic option
10.3390/medicina59061114 · 2023 · External reference
Morphea patients treated with platelet rich plasma: a pilot study
2022 · External reference
Platelet-rich plasma for resistant oral erosions of pemphigus vulgaris: a pilot study
10.1111/wrr.12363 · 2015 · External reference
Role of intralesional platelet-rich plasma (PRP) therapy in the treatment of recalcitrant oral ulcers of pemphigus vulgaris
10.18231/j.ijced.2024.077 · 2024 · External reference
Recalcitrant oral involvement in pemphigus vulgaris successfully treated with platelet-rich plasma
10.23736/s2784-8671.20.06664-x · 2020 · External reference
Topical applications of heterologous platelet rich plasma (PRP) for refractory gingival lesions in autoimmune blistering diseases
10.23736/s2784-8671.23.07696-x · 2024 · External reference
Oral pemphigoid recalcitrant lesion treated with PRGF infiltration. Case report
10.3390/dj9110137 · 2021 · External reference
Y FY, S D. Application of topical autologous platelet-rich plasma for treatment of pemphigus foliaceus wounds: a case report bioscientia medicina
10.37275/bsm.v6i12.625 · 2022 · External reference
Autologous platelet-rich plasma and triamcinolone acetonide intralesional injection in the treatment of oral erosions of pemphigus vulgaris: a pilot study
10.1007/s00403-018-1824-x · 2018 · External reference
Adjunct treatment with platelet-rich plasma for the treatment of inflammatory alopecia in an adult filipino female with systemic lupus erythematosus
10.4103/jpds.jpds_33_24 · 2024 · External reference
Platelet rich plasma for the treatment of scarring alopecia due to discoid lupus erythematosus
10.36849/jdd.5933 · 2022 · External reference
Halting the progression of cicatricial alopecia with injectable platelet-rich fibrin
10.4103/ijt.ijt_116_21 · 2023 · External reference
Effectiveness of platelet derivatives in neuropathic pain management: a systematic review
10.1016/j.biopha.2024.117507 · 2024 · External reference
Morphea (localized scleroderma)
10.1001/jamadermatol.2013.5079 · ExternalCitation · doi-reference
Global skin disease morbidity and mortality: an update from the global burden of disease study 2013
10.1001/jamadermatol.2016.5538 · ExternalCitation · doi-reference
Autoimmune diseases in patients with cutaneous lupus erythematosus
10.1001/jamadermatol.2018.0616 · ExternalCitation · doi-reference
The global prevalence of seborrheic dermatitis: a systematic review and meta-analysis
10.1001/jamadermatol.2024.1987 · ExternalCitation · doi-reference
Long-term effectiveness and reasons for discontinuation of dupilumab in patients with atopic dermatitis
10.1001/jamadermatol.2024.2517 · ExternalCitation · doi-reference
Prevalence of hidradenitis suppurativa: a meta-analysis of global hidradenitis suppurativa atlas studies
10.1001/jamadermatol.2025.2373 · ExternalCitation · doi-reference
The epithelial barrier theory proposes a comprehensive explanation for the origins of allergic and other chronic non-communicable diseases
10.1002/1873-3468.70113 · ExternalCitation · doi-reference
Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infection
10.1002/adhm.201200465 · ExternalCitation · doi-reference
Characterization of distinct microbiota associated with androgenetic alopecia patients treated and untreated with platelet-rich plasma (PRP)
10.1002/ame2.12414 · ExternalCitation · doi-reference
Understanding the role of type I interferons in cutaneous lupus and dermatomyositis: toward better therapeutics
10.1002/art.42983 · ExternalCitation · doi-reference
Efficacy of intralesional injections of platelet-rich plasma in patients with oral lichen planus: a pilot randomized clinical trial
10.1002/cre2.550 · ExternalCitation · doi-reference
Skin immunity and inflammation: cellular interactions and communication
10.1002/cti2.70053 · ExternalCitation · doi-reference
Radiation dermatitis: a comparative review of prevention and management
10.1002/der2.70043 · ExternalCitation · doi-reference
Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors
10.1002/eji.201646680 · ExternalCitation · doi-reference
The IFN-γ-CXCL9/CXCL10-CXCR3 axis in vitiligo: pathological mechanism and treatment
10.1002/eji.202250281 · ExternalCitation · doi-reference
The efficacy of platelet-rich plasma in facial lichen planus pigmentosus: a prospective pilot study
10.1002/hsr2.70455 · ExternalCitation · doi-reference
Anti-inflammation effects of injectable platelet-rich fibrin via macrophages and dendritic cells
10.1002/jbm.a.36792 · ExternalCitation · doi-reference
Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF
10.1002/jcp.22274 · ExternalCitation · doi-reference
Platelet-rich plasma promotes the regeneration of cartilage engineered by mesenchymal stem cells and collagen hydrogel via the TGF-β/SMAD signaling pathway
10.1002/jcp.28211 · ExternalCitation · doi-reference
Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-α and IL-1
10.1002/jor.22532 · ExternalCitation · doi-reference
Alopecia areata: pathogenesis, diagnosis, and therapies
10.1002/mco2.70182 · ExternalCitation · doi-reference
TNF-mediated inflammatory disease
10.1002/path.2287 · ExternalCitation · doi-reference
Allogeneic platelet-rich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing
10.1002/term.2361 · ExternalCitation · doi-reference
Wnt5a/Platelet-rich plasma synergistically inhibits IL-1β-induced inflammatory activity through NF-κB signaling pathway and prevents cartilage damage and promotes meniscus regeneration
10.1002/term.3198 · ExternalCitation · doi-reference
Platelet-rich plasma in the treatment of scars, to suggest or not to suggest? A systematic review and meta-analysis
10.1002/term.3338 · ExternalCitation · doi-reference
Dermatologic and mucocutaneous disorders
10.1007/978-3-030-74720-6_57 · ExternalCitation · doi-reference
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): immunologic reactions: oncologic
10.1007/978-3-319-74588-6_195 · ExternalCitation · doi-reference
Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study
10.1007/s00068-018-0957-0 · ExternalCitation · doi-reference
Effect of two different preparations of platelet-rich plasma on synoviocytes
10.1007/s00167-014-3113-3 · ExternalCitation · doi-reference
The effect of lipofilling and platelet-rich plasma on patients with moderate-severe vulvar lichen sclerosus who were non-responders to topical clobetasol propionate: a randomized pilot study
10.1007/s00266-021-02718-1 · ExternalCitation · doi-reference
Autologous fat granules combined with PRP treat hypertrophic scars through TGF-β/Smad signaling pathway
10.1007/s00266-025-05136-9 · ExternalCitation · doi-reference
Evaluation of the efficacy, safety, and satisfaction rates of platelet-rich plasma, non-cross-linked hyaluronic acid, and their combination in patients with acne scars treated with fractional CO laser: a randomized, double-blind, split-face comparative study
10.1007/s00266-025-05359-w · ExternalCitation · doi-reference
Use of platelet-rich plasma in rheumatic diseases
10.1007/s00296-024-05776-1 · ExternalCitation · doi-reference
Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review
10.1007/s00403-018-1808-x · ExternalCitation · doi-reference
Autologous platelet-rich plasma and triamcinolone acetonide intralesional injection in the treatment of oral erosions of pemphigus vulgaris: a pilot study
10.1007/s00403-018-1824-x · ExternalCitation · doi-reference
Fluid platelet-rich fibrin (PRF) versus platelet-rich plasma (PRP) in the treatment of atrophic acne scars: a comparative study
10.1007/s00403-022-02511-3 · ExternalCitation · doi-reference
de la Cruz Cea L, Oreja Cuesta AB. Mid-term symptomatic relief after platelet-rich plasma infiltration in vulvar lichen sclerosus
10.1007/s00403-023-02529-1 · ExternalCitation · doi-reference
Is there a role for platelet rich plasma injection in vulvar lichen sclerosus? A self-controlled pilot study
10.1007/s00404-024-07424-2 · ExternalCitation · doi-reference
Platelet gel in cutaneous radiation dermatitis
10.1007/s00520-012-1635-0 · ExternalCitation · doi-reference
Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study
10.1007/s00784-020-03702-w · ExternalCitation · doi-reference
Cost of illness of oral lichen planus: a multicenter university hospital-based outpatient observational study
10.1007/s00784-021-04353-1 · ExternalCitation · doi-reference
Clinical evaluation of efficacy of intralesional platelet-rich plasma injection versus 1064 nm long-pulsed Neodymium: YAG laser in the treatment of inflammatory acne vulgaris in adolescent and post-adolescent patients: a prospective randomized split-face comparative study
10.1007/s10103-022-03510-6 · ExternalCitation · doi-reference
Platelet-rich plasma as an adjuvant therapy to fractional ablative carbon dioxide lasers for cutaneous repair: a complementary treatment for atrophic acne scarring
10.1007/s10103-024-04192-y · ExternalCitation · doi-reference
Platelet-rich plasma-derived exosomes accelerate the healing of diabetic foot ulcers by promoting macrophage polarization toward the M2 phenotype
10.1007/s10238-025-01651-w · ExternalCitation · doi-reference
Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights
10.1007/s10787-025-01642-z · ExternalCitation · doi-reference
Autologous platelet-rich plasma (PRP) in chronic penile lichen sclerosus: the impact on tissue repair and patient quality of life
10.1007/s11255-017-1523-0 · ExternalCitation · doi-reference
Biologics and small molecule inhibitors: an update in therapies for allergic and immunologic skin diseases
10.1007/s11882-022-01047-w · ExternalCitation · doi-reference
Platelet-rich plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes
10.1007/s11999-015-4179-z · ExternalCitation · doi-reference
Innate immunity in atopic dermatitis
10.1007/s12016-010-8227-x · ExternalCitation · doi-reference
Comorbidity burden among patients with vitiligo in the United States: a large-scale retrospective claims database analysis
10.1007/s13555-023-01001-2 · ExternalCitation · doi-reference
The microbiome and acne: perspectives for treatment
10.1007/s13555-023-01079-8 · ExternalCitation · doi-reference
Association between scalp microbiota imbalance, disease severity, and systemic inflammatory markers in alopecia areata
10.1007/s13555-024-01281-2 · ExternalCitation · doi-reference
A narrative review of pemphigoid diseases: bridging associations, comorbidities, and management
10.1007/s13555-025-01444-9 · ExternalCitation · doi-reference
Platelet-rich plasma in the management of alopecia: a systematic review and meta-analysis of clinical evidence
10.1007/s13555-025-01542-8 · ExternalCitation · doi-reference
Global burden of skin disease: inequities and innovations
10.1007/s13671-017-0192-7 · ExternalCitation · doi-reference
Skin barrier function and atopic dermatitis
10.1007/s13671-018-0232-y · ExternalCitation · doi-reference
Prevalence and species distribution of Candida bloodstream infection in children and adults in two teaching university hospitals in Egypt: first report of Candida kefyr
10.1007/s15010-022-01888-7 · ExternalCitation · doi-reference
Stevens-Johnson syndrome and toxic epidermal necrolysis: an update
10.1007/s40257-015-0158-0 · ExternalCitation · doi-reference
Biological therapy of refractory ulcerative oral lichen planus with plasma rich in growth factors
10.1007/s40257-017-0277-x · ExternalCitation · doi-reference
Comorbid conditions associated with alopecia areata: a systematic review and meta-analysis
10.1007/s40257-023-00805-4 · ExternalCitation · doi-reference
Frontal fibrosing alopecia: an update
10.1007/s40257-024-00912-w · ExternalCitation · doi-reference
Biomolecules in the treatment of lichen planus refractory to corticosteroid therapy: clinical and histopathological assessment
10.1016/j.aanat.2017.12.006 · ExternalCitation · doi-reference
Incidence of radiodermatitis and factors associated with its severity in women with breast cancer: a cohort study
10.1016/j.abd.2023.01.004 · ExternalCitation · doi-reference
Overlap between psoriasis and atopic dermatitis: therapeutic approach
10.1016/j.ad.2025.104541 · ExternalCitation · doi-reference
Lichen sclerosus and squamous cell carcinoma
10.1016/j.adengl.2011.05.004 · ExternalCitation · doi-reference
Skin barrier defects in atopic dermatitis: from old idea to new opportunity
10.1016/j.alit.2021.11.006 · ExternalCitation · doi-reference
Filaggrin and beyond: new insights into the skin barrier in atopic dermatitis and allergic diseases, from genetics to therapeutic perspectives
10.1016/j.anai.2023.09.009 · ExternalCitation · doi-reference
Gene expression based evidence of innate immune response activation in the epithelium with oral lichen planus
10.1016/j.archoralbio.2013.12.010 · ExternalCitation · doi-reference
Platelet-rich plasma: fundamentals and clinical applications
10.1016/j.arthro.2021.07.003 · ExternalCitation · doi-reference
Cutaneous lupus erythematosus: diagnosis and treatment. Best practice & research
10.1016/j.berh.2013.07.008 · ExternalCitation · doi-reference
Effectiveness of platelet derivatives in neuropathic pain management: a systematic review
10.1016/j.biopha.2024.117507 · ExternalCitation · doi-reference
Effectiveness of topical administration of platelet-rich plasma on the healing of methicillin-resistant Staphylococcus aureus-infected full-thickness wound model
10.1016/j.bjps.2022.11.059 · ExternalCitation · doi-reference
Platelet alpha-granules: basic biology and clinical correlates
10.1016/j.blre.2009.04.001 · ExternalCitation · doi-reference
Efficacy of topical platelet-rich plasma and chitosan co-administration on Candida albicans-infected partial thickness burn wound healing
10.1016/j.burns.2020.05.019 · ExternalCitation · doi-reference
Mucocutaneous diseases
10.1016/j.cden.2019.08.009 · ExternalCitation · doi-reference
Pattern recognition receptors and inflammation
10.1016/j.cell.2010.01.022 · ExternalCitation · doi-reference
Platelet-rich plasma-derived extracellular vesicles inhibit NF-κB/NLRP3 pathway-mediated pyroptosis in intervertebral disc degeneration via the MALAT1/microRNA-217/SIRT1 axis
10.1016/j.cellsig.2024.111106 · ExternalCitation · doi-reference
Comorbidities associated with psoriatic arthritis: review and update
10.1016/j.clim.2020.108397 · ExternalCitation · doi-reference
Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis
10.1016/j.clindermatol.2020.06.016 · ExternalCitation · doi-reference
The genetics of pediatric cutaneous autoimmunity: the sister diseases vitiligo and alopecia areata
10.1016/j.clindermatol.2022.02.009 · ExternalCitation · doi-reference
Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
10.1016/j.coi.2017.08.008 · ExternalCitation · doi-reference
Innate immune sensing by epithelial barriers
10.1016/j.coi.2021.07.014 · ExternalCitation · doi-reference
Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseases
10.1016/j.coi.2024.102493 · ExternalCitation · doi-reference
Platelet-rich plasma (PRP) for the treatment of vulvar lichen sclerosus in a premenopausal woman: a case report
10.1016/j.crwh.2018.e00062 · ExternalCitation · doi-reference
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
10.1016/j.cyto.2014.09.011 · ExternalCitation · doi-reference
Cytokines in psoriasis
10.1016/j.cyto.2014.12.014 · ExternalCitation · doi-reference
Dermatologic health disparities
10.1016/j.det.2011.08.002 · ExternalCitation · doi-reference
Emerging infectious diseases of the skin: a review of clinical and histologic findings
10.1016/j.humpath.2023.07.003 · ExternalCitation · doi-reference
Influence of platelet-rich plasma on the immune response of human monocyte-derived dendritic cells and macrophages stimulated with Aspergillus fumigatus
10.1016/j.ijmm.2016.11.010 · ExternalCitation · doi-reference
Inflammasomes: Threat-assessment organelles of the innate immune system
10.1016/j.immuni.2019.08.005 · ExternalCitation · doi-reference
Platelet-rich plasma-derived exosomes attenuate intervertebral disc degeneration by promoting NLRP3 autophagic degradation in macrophages
10.1016/j.intimp.2022.108962 · ExternalCitation · doi-reference
Intradermal injection of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus
10.1016/j.jaad.2016.07.037 · ExternalCitation · doi-reference
Platelet-rich plasma as an adjunctive treatment in lichen planopilaris
10.1016/j.jaad.2018.09.013 · ExternalCitation · doi-reference
A randomized double-blind placebo-controlled trial of autologous platelet-rich plasma intradermal injections for the treatment of vulvar lichen sclerosus
10.1016/j.jaad.2018.12.060 · ExternalCitation · doi-reference
Dermatomyositis: clinical features and pathogenesis
10.1016/j.jaad.2019.06.1309 · ExternalCitation · doi-reference
Use of platelet-rich plasma in lichen planopilaris and its variants: a retrospective case series demonstrating treatment tolerability without koebnerization
10.1016/j.jaad.2020.06.026 · ExternalCitation · doi-reference
Evaluation of platelet-rich plasma on hair regrowth and lesional T-cell cytokine expression in alopecia areata: a randomized observer-blinded, placebo-controlled, split-head pilot study
10.1016/j.jaad.2020.12.039 · ExternalCitation · doi-reference
Prevalence and treatment patterns of lichen planus
10.1016/j.jaad.2024.09.081 · ExternalCitation · doi-reference
Focused update: guidelines of care for the management of atopic dermatitis in adults
10.1016/j.jaad.2025.05.1386 · ExternalCitation · doi-reference
IL-31: a new link between T cells and pruritus in atopic skin inflammation
10.1016/j.jaci.2005.10.033 · ExternalCitation · doi-reference
Itch: from mechanism to (novel) therapeutic approaches
10.1016/j.jaci.2018.09.005 · ExternalCitation · doi-reference
Comorbidities of atopic dermatitis-what does the evidence say?
10.1016/j.jaci.2022.12.002 · ExternalCitation · doi-reference
Deciding which patients with atopic dermatitis to prioritize for biologics and janus kinase inhibitors
10.1016/j.jaip.2025.04.042 · ExternalCitation · doi-reference
Effect of platelet-rich plasma in refractory vitiligo by promoting the differentiation of dermal melanocyte progenitors via IGFBP-2/RhoA/YAP pathway
10.1016/j.jare.2026.02.057 · ExternalCitation · doi-reference
Induction and maintenance of regulatory T cells by transcription factors and epigenetic modifications
10.1016/j.jaut.2017.07.002 · ExternalCitation · doi-reference
Platelet-rich plasma, a promising adjunctive treatment for vitiligo: a case report
10.1016/j.jdcr.2020.09.021 · ExternalCitation · doi-reference
Long-term control of atopic dermatitis with platelet-rich plasma
10.1016/j.jdcr.2020.10.036 · ExternalCitation · doi-reference
The role of platelet-rich plasma therapy in refractory folliculitis decalvans
10.1016/j.jdcr.2021.04.008 · ExternalCitation · doi-reference
Burden of skin disease and associated socioeconomic status in Europe: an ecologic study from the global burden of disease study 2017
10.1016/j.jdin.2020.07.001 · ExternalCitation · doi-reference
Evaluating the psychosocial burden and unmet needs for health care access among older adults with inflammatory skin disease
10.1016/j.jdin.2024.11.006 · ExternalCitation · doi-reference
The burden of atopic dermatitis: summary of a report for the national eczema association
10.1016/j.jid.2016.07.012 · ExternalCitation · doi-reference
Skin deep: the role of the microbiota in cutaneous autoimmunity
10.1016/j.jid.2021.12.005 · ExternalCitation · doi-reference
Halting the vicious cycle of atopic dermatitis: empowered by scientific understanding
10.1016/j.jid.2024.03.003 · ExternalCitation · doi-reference
The central roles of keratinocytes in coordinating skin immunity
10.1016/j.jid.2024.06.1280 · ExternalCitation · doi-reference
191 the burden of mental health in inflammatory skin diseases: depression, anxiety, and quality of life in psoriasis, atopic dermatitis, and hidradenitis suppurativa
10.1016/j.jid.2025.09.197 · ExternalCitation · doi-reference
An overview of the biology of platelet-rich plasma and microneedling as potential treatments for alopecia areata
10.1016/j.jisp.2017.10.002 · ExternalCitation · doi-reference
Comparative evaluation of effectiveness of autologous platelet rich plasma and intralesional corticosteroids in the management of erosive oral Lichen planus- a clinical study
10.1016/j.jobcr.2020.09.008 · ExternalCitation · doi-reference
Regenerative potential of platelet concentrates in chronic oral mucosal lesions
10.1016/j.jobcr.2024.02.007 · ExternalCitation · doi-reference
Platelet-rich plasma: evidence to support its use
10.1016/j.joms.2003.12.003 · ExternalCitation · doi-reference
Xenogeneic platelet-rich plasma lotion for preventing acute radiation dermatitis in patients with breast cancer undergoing radiotherapy: An open-label, randomized controlled trial
10.1016/j.jpra.2024.11.017 · ExternalCitation · doi-reference
Costs of psoriasis in Europe. A systematic review of the literature
10.1016/j.jval.2014.08.2112 · ExternalCitation · doi-reference
Epidemiology of cutaneous lupus erythematosus among adults over four decades (1976–2018): a lupus midwest network (LUMEN) study
10.1016/j.mayocp.2022.06.022 · ExternalCitation · doi-reference
Targeting the IFN-γ/CXCL10 pathway in lichen planus
10.1016/j.mehy.2016.04.042 · ExternalCitation · doi-reference
Host responses to Candida albicans: Th17 cells and mucosal candidiasis
10.1016/j.micinf.2010.03.013 · ExternalCitation · doi-reference
Inflammasome, inflammation, and tissue homeostasis
10.1016/j.molmed.2018.01.004 · ExternalCitation · doi-reference
Platelet rich plasma extract promotes angiogenesis through the angiopoietin1-Tie2 pathway
10.1016/j.mvr.2013.04.008 · ExternalCitation · doi-reference
Small vessel vasculitis of the skin
10.1016/j.rdc.2014.09.006 · ExternalCitation · doi-reference
Platelet-rich plasma promotes recruitment of macrophages in the process of tendon healing
10.1016/j.reth.2020.03.009 · ExternalCitation · doi-reference
Characterization of autologous platelet rich plasma (PRP) and its biological effects in patients with Behçet's Disease
10.1016/j.reth.2021.08.010 · ExternalCitation · doi-reference
Skin fibrosis: models and mechanisms
10.1016/j.retram.2016.06.003 · ExternalCitation · doi-reference
The epithelial barrier: the gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions
10.1016/j.smim.2023.101846 · ExternalCitation · doi-reference
Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)
10.1016/j.tibtech.2008.11.009 · ExternalCitation · doi-reference
Platelet-rich plasma contributes to chondroprotection by repairing mitochondrial function via AMPK/NF-κB signaling in osteoarthritic chondrocytes
10.1016/j.tice.2022.101830 · ExternalCitation · doi-reference
Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship
10.1016/j.tim.2017.11.008 · ExternalCitation · doi-reference
Hidradenitis suppurativa: host-microbe and immune pathogenesis underlie important future directions
10.1016/j.xjidi.2021.100001 · ExternalCitation · doi-reference
T-cell adhesion in healthy and inflamed skin
10.1016/j.xjidi.2021.100014 · ExternalCitation · doi-reference
Cutaneous and gut dysbiosis in alopecia areata: a review
10.1016/j.xjidi.2025.100363 · ExternalCitation · doi-reference
Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism
10.1016/s0002-9440(10)63649-8 · ExternalCitation · doi-reference
Pemphigoid diseases
10.1016/s0140-6736(12)61140-4 · ExternalCitation · doi-reference
Psoriasis
10.1016/s0140-6736(14)61909-7 · ExternalCitation · doi-reference
Atopic dermatitis
10.1016/s0140-6736(15)00149-x · ExternalCitation · doi-reference
Hidradenitis suppurativa
10.1016/s0140-6736(24)02475-9 · ExternalCitation · doi-reference
The immunology of psoriasis and biologic immunotherapy
10.1016/s0190-9622(03)01134-4 · ExternalCitation · doi-reference
Estimating the burden of vitiligo: a systematic review and modelling study
10.1016/s2468-2667(24)00026-4 · ExternalCitation · doi-reference
TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes
10.1038/jid.2010.351 · ExternalCitation · doi-reference
Propionibacterium acnes Induces IL-1β secretion via the NLRP3 inflammasome in human monocytes
10.1038/jid.2013.309 · ExternalCitation · doi-reference
The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions
10.1038/jid.2013.446 · ExternalCitation · doi-reference
The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries
10.1038/jid.2014.530 · ExternalCitation · doi-reference
Molecular mechanisms regulating TGF-β-induced Foxp3 expression
10.1038/mi.2010.7 · ExternalCitation · doi-reference
Wound repair and regeneration
10.1038/nature07039 · ExternalCitation · doi-reference
Origin and physiological roles of inflammation
10.1038/nature07201 · ExternalCitation · doi-reference
T(H)-17 cells in the circle of immunity and autoimmunity
10.1038/ni0407-345 · ExternalCitation · doi-reference
Immune surveillance in the skin: mechanisms and clinical consequences
10.1038/nri1310 · ExternalCitation · doi-reference
How dying cells alert the immune system to danger
10.1038/nri2215 · ExternalCitation · doi-reference
Skin immune sentinels in health and disease
10.1038/nri2622 · ExternalCitation · doi-reference
Sterile inflammation: sensing and reacting to damage
10.1038/nri2873 · ExternalCitation · doi-reference
Freedman J. Platelets and the immune continuum
10.1038/nri2956 · ExternalCitation · doi-reference
Epithelial antimicrobial defence of the skin and intestine
10.1038/nri3228 · ExternalCitation · doi-reference
Mechanisms regulating skin immunity and inflammation
10.1038/nri3646 · ExternalCitation · doi-reference
Type I interferons in infectious disease
10.1038/nri3787 · ExternalCitation · doi-reference
Platelet-rich plasma for managing pain and inflammation in osteoarthritis
10.1038/nrrheum.2013.141 · ExternalCitation · doi-reference
TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers
10.1038/onc.2012.171 · ExternalCitation · doi-reference
Microbiota in health and diseases
10.1038/s41392-022-00974-4 · ExternalCitation · doi-reference
The IL-17 family in diseases: from bench to bedside
10.1038/s41392-023-01620-3 · ExternalCitation · doi-reference
Mucosal immune response in biology, disease prevention and treatment
10.1038/s41392-024-02043-4 · ExternalCitation · doi-reference
Advances in the pathogenesis of psoriasis: from keratinocyte perspective
10.1038/s41419-022-04523-3 · ExternalCitation · doi-reference
Interaction between microbiota and immunity in health and disease
10.1038/s41422-020-0332-7 · ExternalCitation · doi-reference
Bullous pemphigoid
10.1038/s41572-025-00595-5 · ExternalCitation · doi-reference
The immunological anatomy of the skin
10.1038/s41577-018-0084-5 · ExternalCitation · doi-reference
Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
10.1038/s41577-021-00538-7 · ExternalCitation · doi-reference
The role of platelets in immune-mediated inflammatory diseases
10.1038/s41577-023-00834-4 · ExternalCitation · doi-reference
Host-microbiota interactions in immune-mediated diseases
10.1038/s41579-020-0367-2 · ExternalCitation · doi-reference
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
10.1038/s41580-020-0230-3 · ExternalCitation · doi-reference
A virtual memory CD8(+) T cell-originated subset causes alopecia areata through innate-like cytotoxicity
10.1038/s41590-023-01547-5 · ExternalCitation · doi-reference
Platelet-rich plasma respectively reduces and promotes adipogenic and myofibroblastic differentiation of human adipose-derived stromal cells via the TGFβ signalling pathway
10.1038/s41598-017-03113-0 · ExternalCitation · doi-reference
In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis
10.1038/s41598-021-90174-x · ExternalCitation · doi-reference
Global burden of alopecia areata from 1990 to 2019 and emerging treatment trends analyzed through GBD 2019 and bibliometric data
10.1038/s41598-025-07224-x · ExternalCitation · doi-reference
Integrative genetics and multiomics analysis reveal mechanisms and therapeutic targets in vitiligo highlighting JAK STAT pathway regulation of CTSS
10.1038/s41598-025-86134-4 · ExternalCitation · doi-reference
Platelet-rich plasma as a potential antimicrobial agent against multidrug-resistant bacteria in diabetic foot infections
10.1038/s41598-025-97418-0 · ExternalCitation · doi-reference
Platelet-rich plasma relieves inflammation and pain by regulating M1/M2 macrophage polarization in knee osteoarthritis rats
10.1038/s41598-025-97501-6 · ExternalCitation · doi-reference
Platelet-rich plasma and IL-1β antagonist receptor peptide attenuate the inflammatory process of muscle injury in wistar rats
10.1038/s41598-025-98998-7 · ExternalCitation · doi-reference
NF-κB signaling in inflammation
10.1038/sigtrans.2017.23 · ExternalCitation · doi-reference
Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus
10.1038/sj.jid.5700231 · ExternalCitation · doi-reference
Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life
10.1038/sj.jid.5701239 · ExternalCitation · doi-reference
Inflammatory events are involved in acne lesion initiation
10.1046/j.1523-1747.2003.12321.x · ExternalCitation · doi-reference
The role of human platelet preparation for toll-like receptors 2 and 4 related platelet responsiveness
10.1055/s-0039-1685495 · ExternalCitation · doi-reference
Alopecia areata
10.1056/nejmra1103442 · ExternalCitation · doi-reference
Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair
10.1073/pnas.0306068101 · ExternalCitation · doi-reference
Interleukin-31 pathway and its role in atopic dermatitis: a systematic review
10.1080/09546634.2017.1290205 · ExternalCitation · doi-reference
Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata
10.1080/09546634.2018.1544405 · ExternalCitation · doi-reference
Usefulness of video thermography in the evaluation of platelet-rich plasma effectiveness in vulvar lichen sclerosus: preliminary study
10.1080/09546634.2019.1685644 · ExternalCitation · doi-reference
Platelet rich plasma injection versus topical erythromycin 2% in treatment of acne vulgaris
10.1080/09546634.2020.1793884 · ExternalCitation · doi-reference
Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP?
10.1080/09546634.2020.1854650 · ExternalCitation · doi-reference
Cytokine alterations in psoriasis: an updated review
10.1080/1744666x.2022.2011720 · ExternalCitation · doi-reference
Platelet lysate induces in vitro wound healing of human keratinocytes associated with a strong proinflammatory response
10.1089/ten.tea.2010.0729 · ExternalCitation · doi-reference
Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution
10.1089/ten.tea.2012.0225 · ExternalCitation · doi-reference
Platelet-rich plasma for the treatment of tissue infection: preparation and clinical evaluation
10.1089/ten.teb.2018.0309 · ExternalCitation · doi-reference
Epidermal growth factor and epidermal growth factor receptor: the yin and yang in the treatment of cutaneous wounds and cancer
10.1089/wound.2011.0326 · ExternalCitation · doi-reference
Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study
10.1093/bjd/ljad339 · ExternalCitation · doi-reference
Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization
10.1093/burnst/tkaa028 · ExternalCitation · doi-reference
Epidemiology of atopic dermatitis: a global worldwide study
10.1093/ced/llaf233 · ExternalCitation · doi-reference
Effect of platelet-rich plasma versus platelet lysate on imiquimod-induced psoriasis-like skin inflammation in adult male albino rat model: a histological, immunohistochemical, and ultrastructural study
10.1093/mam/ozag017 · ExternalCitation · doi-reference
Nummular eczema and contact allergy: a retrospective study
10.1097/der.0b013e318260d5a0 · ExternalCitation · doi-reference
Use of platelet-rich plasma for vulvovaginal autoimmune conditions like lichen sclerosus
10.1097/gox.0000000000001124 · ExternalCitation · doi-reference
Alopecia areata treated with advanced platelet-rich fibrin using micronization
10.1097/gox.0000000000004032 · ExternalCitation · doi-reference
Skin and subcutaneous disease burden, 1990–2021: a GBD review
10.1097/js9.0000000000004028 · ExternalCitation · doi-reference
Evaluating in office surgery followed by platelet rich plasma to treat lichen sclerosus
10.1097/lgt.0000000000000491 · ExternalCitation · doi-reference
Homologous platelet gel on radiation-induced dermatitis in a patient receiving head and neck radiotherapy plus cetuximab: a case report
10.1097/md.0000000000034779 · ExternalCitation · doi-reference
Insights into microbial dysbiosis and Cutibacterium acnes CAMP factor interactions in acne vulgaris
10.1099/mgen.0.001449 · ExternalCitation · doi-reference
The nuclear factor NF-kappaB pathway in inflammation
10.1101/cshperspect.a001651 · ExternalCitation · doi-reference
Updates in pathogenesis of pemphigus vulgaris
10.1111/1346-8138.70077 · ExternalCitation · doi-reference
Dysbiosis in the pathogenesis of atopic dermatitis
10.1111/1346-8138.70191 · ExternalCitation · doi-reference
Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis
10.1111/1523-1747.ep12876121 · ExternalCitation · doi-reference
The value of adding platelet-rich plasma (PRP) to noncultured epidermal cell suspension (NCECS) in surgical treatment of stable resistant vitiligo: a self-controlled randomised double-blinded study
10.1111/ajd.14080 · ExternalCitation · doi-reference
T-cell subsets in the skin and their role in inflammatory skin disorders
10.1111/all.15104 · ExternalCitation · doi-reference
Biologics to treat atopic dermatitis: effectiveness, safety, and future directions
10.1111/all.70061 · ExternalCitation · doi-reference
Incidence and prevalence of rosacea: a systematic review and meta-analysis
10.1111/bjd.16481 · ExternalCitation · doi-reference
Dysregulation of the epithelial barrier by environmental and other exogenous factors
10.1111/cod.13959 · ExternalCitation · doi-reference
Platelet-rich plasma as a novel treatment for lichen planopillaris
10.1111/dth.12343 · ExternalCitation · doi-reference
Clinical efficacy of platelet rich plasma in combination with methotrexate in chronic plaque psoriatic patients
10.1111/dth.12388 · ExternalCitation · doi-reference
Platelet-rich plasma for treatment resistant frontal fibrosing alopecia: a case report
10.1111/dth.13072 · ExternalCitation · doi-reference
Platelet-rich plasma for male genital lichen sclerosus resistant to conventional therapy: first prospective study
10.1111/dth.14032 · ExternalCitation · doi-reference
Adipose tissue stromal vascular fraction and adipose tissue stromal vascular fraction plus platelet-rich plasma grafting: new regenerative perspectives in genital lichen sclerosus
10.1111/dth.14277 · ExternalCitation · doi-reference
Effect of platelet-rich plasma on the outcome of mini-punch grafting procedure in localized stable vitiligo: clinical evaluation and relation to lesional basic fibroblast growth factor
10.1111/dth.14738 · ExternalCitation · doi-reference
Evaluation of the efficacy and safety of platelet rich plasma injection in treatment of rosacea
10.1111/dth.15049 · ExternalCitation · doi-reference
Ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma in the treatment of atrophic acne scars: a systematic review and meta-analysis
10.1111/dth.15888 · ExternalCitation · doi-reference
The skin barrier: epidermis vs. environment
10.1111/exd.13731 · ExternalCitation · doi-reference
Hair follicle immune privilege and its collapse in alopecia areata
10.1111/exd.14155 · ExternalCitation · doi-reference
Platelet-derived extracellular vesicles alleviate psoriatic inflammation via mitochondrial transfer to macrophages
10.1111/exd.70152 · ExternalCitation · doi-reference
Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix
10.1111/iwj.12117 · ExternalCitation · doi-reference
Accelerated wound healing after wide excisions in hidradenitis suppurativa using autologous split-thickness skin grafting and platelet-rich plasma
10.1111/iwj.12673 · ExternalCitation · doi-reference
Current art of combination therapy with autologous platelet-rich plasma for stable vitiligo: a meta-analysis
10.1111/iwj.13524 · ExternalCitation · doi-reference
An evaluation of the bacteriostatic effect of platelet-rich plasma
10.1111/iwj.13545 · ExternalCitation · doi-reference
Reduction of serum interleukin-5 levels reflect clinical improvement in patients with atopic dermatitis
10.1111/j.1346-8138.2001.tb00124.x · ExternalCitation · doi-reference
Growth factors and cytokines in wound healing
10.1111/j.1524-475x.2008.00410.x · ExternalCitation · doi-reference
The skin: an indispensable barrier
10.1111/j.1600-0625.2008.00786.x · ExternalCitation · doi-reference
Mucocutaneous disorders
10.1111/j.1600-0757.1998.tb00140.x · ExternalCitation · doi-reference
The role of TGF-β1/Smad2/3 pathway in platelet-rich plasma in retarding intervertebral disc degeneration
10.1111/jcmm.12847 · ExternalCitation · doi-reference
The use of PRP (platelet-rich plasma) in patients affected by genital lichen sclerosus: clinical analysis and results
10.1111/jdv.15190 · ExternalCitation · doi-reference
Neuroimmune interactions in chronic itch of atopic dermatitis
10.1111/jdv.15973 · ExternalCitation · doi-reference
The burden of neurological comorbidities in six autoimmune bullous diseases: a population-based study
10.1111/jdv.17465 · ExternalCitation · doi-reference
Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe
10.1111/jdv.18168 · ExternalCitation · doi-reference
Gender differences in adult atopic dermatitis and clinical implication: results from a nationwide multicentre study
10.1111/jdv.19580 · ExternalCitation · doi-reference
Psychosocial burden of autoimmune blistering diseases: a comprehensive survey study
10.1111/jdv.20156 · ExternalCitation · doi-reference
Update on cutaneous lupus erythematosus pathogenesis, diagnosis and management
10.1111/jdv.70186 · ExternalCitation · doi-reference
Systematic review of the use of platelet-rich plasma in aesthetic dermatology
10.1111/jocd.12167 · ExternalCitation · doi-reference
The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study
10.1111/jocd.12194 · ExternalCitation · doi-reference
Relationship between transient receptor potential vanilloid-1 expression and the intensity of sensitive skin symptoms
10.1111/jocd.12204 · ExternalCitation · doi-reference
The use of biostatic human amnion and platelet-rich plasma in topical treatment of toxic epidermal necrolysis-a case report
10.1111/jocd.13864 · ExternalCitation · doi-reference
Possible clinical efficacy and tolerability of platelet-rich plasma with atopic dermatitis
10.1111/jocd.14170 · ExternalCitation · doi-reference
Excellent response with platelet-rich plasma treatment in a case of steroid-induced rosacea-like dermatitis
10.1111/jocd.14469 · ExternalCitation · doi-reference
Efficacy of autologous platelet-rich plasma in the treatment of vitiligo: a 10-patient prospective study
10.1111/jocd.15050 · ExternalCitation · doi-reference
Intralesional injection of platelet-rich plasma versus steroid in the treatment of oral lichen planus
10.1111/jocd.15622 · ExternalCitation · doi-reference
Platelet-rich plasma as a new and successful treatment for lichen planopilaris: a controlled blinded randomized clinical trial
10.1111/jocd.16302 · ExternalCitation · doi-reference
A systematic review of case series and clinical trials investigating regenerative medicine for the treatment of vitiligo
10.1111/jocd.16660 · ExternalCitation · doi-reference
Stigmatization and psychosocial burden in acne patients
10.1111/jocd.16678 · ExternalCitation · doi-reference
Successful treatment of complex and refractory rosacea using platelet-rich plasma injection therapy: case series and review of the literature
10.1111/jocd.70031 · ExternalCitation · doi-reference
Platelet-released growth factors (PRGFs) activate NRF2-ARE and modulate inflammatory response in an nrf2-dependent manner in primary human keratinocytes
10.1111/jocd.70228 · ExternalCitation · doi-reference
Efficacy and safety of combined platelet-rich plasma with fractional laser for adult patients with vitiligo: a systematic review and meta-analysis of randomized controlled trials
10.1111/jocd.70245 · ExternalCitation · doi-reference
Platelets provoke distinct dynamics of immune responses by differentially regulating CD4+ T-cell proliferation
10.1111/jth.12612 · ExternalCitation · doi-reference
Platelets in inflammation and immunity
10.1111/jth.12730 · ExternalCitation · doi-reference
Platelet-conditioned media induces an anti-inflammatory macrophage phenotype through EP4
10.1111/jth.15172 · ExternalCitation · doi-reference
Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis
10.1111/odi.13323 · ExternalCitation · doi-reference
Immune mechanisms in oral lichen planus
10.1111/odi.14142 · ExternalCitation · doi-reference
Efficacy of injectable platelet-rich fibrin in the treatment of symptomatic oral lichen planus
10.1111/odi.14261 · ExternalCitation · doi-reference
Oral microbial dysbiosis and pathogenic functional shifts in mucosa-dominant pemphigus vulgaris and low-risk mucous membrane pemphigoid
10.1111/odi.70207 · ExternalCitation · doi-reference
Mini skin graft and platelet-rich fibrin combination following hidradenitis suppurativa surgery: a pediatric case report
10.1111/pde.15979 · ExternalCitation · doi-reference
A triple combination of latanoprost, fractional CO laser, and platelet-rich plasma in localized vitiligo: a clinical and histopathologic study
10.1111/phpp.12944 · ExternalCitation · doi-reference
How to explain the beneficial effects of platelet-rich plasma
10.1111/prd.12565 · ExternalCitation · doi-reference
The use of platelet-rich plasma in wound healing and vitiligo: a systematic review and meta-analysis
10.1111/srt.13444 · ExternalCitation · doi-reference
Platelet-rich plasma for resistant oral erosions of pemphigus vulgaris: a pilot study
10.1111/wrr.12363 · ExternalCitation · doi-reference
In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood
10.11138/mltj/2014.4.1.079 · ExternalCitation · doi-reference
Dialogue between skin microbiota and immunity
10.1126/science.1260144 · ExternalCitation · doi-reference
Mucosal bacteria modulate candida albicans virulence in oropharyngeal candidiasis
10.1128/mbio.01937-21 · ExternalCitation · doi-reference
Cutaneous dysbiosis in girls with vulvar lichen sclerosus
10.1128/spectrum.02674-24 · ExternalCitation · doi-reference
Janus kinase inhibitors in autoimmune diseases
10.1136/annrheumdis-2012-202576 · ExternalCitation · doi-reference
Psoriasis: epidemiology, clinical features, and quality of life
10.1136/ard.2004.033217 · ExternalCitation · doi-reference
Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses
10.1136/sextrans-2024-056307 · ExternalCitation · doi-reference
The JAK-STAT pathway: impact on human disease and therapeutic intervention
10.1146/annurev-med-051113-024537 · ExternalCitation · doi-reference
IL-17 and Th17 cells
10.1146/annurev.immunol.021908.132710 · ExternalCitation · doi-reference
Regulation of wound healing by growth factors and cytokines
10.1152/physrev.2003.83.3.835 · ExternalCitation · doi-reference
DAMPening inflammation by modulating TLR signalling
10.1155/2010/672395 · ExternalCitation · doi-reference
Activated platelets induce an anti-inflammatory response of monocytes/macrophages through cross-regulation of PGE and cytokines
10.1155/2017/1463216 · ExternalCitation · doi-reference
Platelet-released growth factors induce differentiation of primary keratinocytes
10.1155/2017/5671615 · ExternalCitation · doi-reference
Antibacterial activity of leukocyte- and platelet-rich plasma: an in vitro study
10.1155/2018/9471723 · ExternalCitation · doi-reference
Mechanism of platelet-rich plasma in promoting diabetic wound healing via the PI3K/AKT signaling pathway to regulate collagen synthesis and angiogenesis
10.1155/jdr/1254597 · ExternalCitation · doi-reference
Growth factors and microneedling in alopecia areata: a narrative review
10.1159/000534636 · ExternalCitation · doi-reference
Autologous platelets as a source of proteins for healing and tissue regeneration
10.1160/th03-07-0440 · ExternalCitation · doi-reference
Platelets as immune cells: bridging inflammation and cardiovascular disease
10.1161/01.res.0000252802.25497.b7 · ExternalCitation · doi-reference
Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo
10.1177/03000605221119646 · ExternalCitation · doi-reference
Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes
10.1177/0363546511419278 · ExternalCitation · doi-reference
The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis
10.1177/0363546513507766 · ExternalCitation · doi-reference
Plasma rich in growth factors as an adjuvant treatment for the management of frontal fibrosing alopecia: a retrospective observational clinical study
10.1177/12034754231177599 · ExternalCitation · doi-reference
Hidradenitis suppurativa and wound management
10.1177/1534734615598890 · ExternalCitation · doi-reference
Platelet-rich plasma improves lipopolysaccharide-induced inflammatory response by upgrading autophagy
10.1177/1721727x221112271 · ExternalCitation · doi-reference
Complexity of platelet-rich plasma: mechanism of action, growth factor utilization and variation in preparation
10.1177/26348535241277625 · ExternalCitation · doi-reference
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
10.1182/blood-2010-04-281717 · ExternalCitation · doi-reference
Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles
10.1182/blood-2013-03-492801 · ExternalCitation · doi-reference
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages
10.1182/blood.v95.4.1158.004k31_1158_1166 · ExternalCitation · doi-reference
Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice
10.1182/bloodadvances.2020002867 · ExternalCitation · doi-reference
Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity
10.1186/1471-2180-13-47 · ExternalCitation · doi-reference
Biologic therapy for autoimmune diseases: an update
10.1186/1741-7015-11-88 · ExternalCitation · doi-reference
Biology of platelet-rich plasma and its clinical application in cartilage repair
10.1186/ar4493 · ExternalCitation · doi-reference
Leukocyte presence does not increase microbicidal activity of platelet-rich plasma in vitro
10.1186/s12866-015-0482-9 · ExternalCitation · doi-reference
Dysbiosis of saliva microbiome in patients with oral lichen planus
10.1186/s12866-020-01733-7 · ExternalCitation · doi-reference
The effects of platelet-rich plasma on zoster-associated pain: a scoping review
10.1186/s12871-025-03426-y · ExternalCitation · doi-reference
Antibacterial and antibiofilm activity of platelet-rich plasma under different activation conditions against multidrug-resistant MRSA isolated from human skin abscesses
10.1186/s12896-025-01078-x · ExternalCitation · doi-reference
Use of platelet-rich plasma (PRP) and injectable platelet-rich fibrin (i-PRF) in oral lichen planus treatment: a systematic review of randomized controlled trials
10.1186/s12903-025-06189-7 · ExternalCitation · doi-reference
Platelet-rich plasma activates AKT signaling to promote wound healing in a mouse model of radiation-induced skin injury
10.1186/s12967-019-2044-7 · ExternalCitation · doi-reference
Systematic literature review evaluating evidence and mechanisms of action for platelet-rich plasma as an antibacterial agent
10.1186/s13019-021-01652-2 · ExternalCitation · doi-reference
Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy
10.1186/s40364-024-00700-y · ExternalCitation · doi-reference
Autoimmune bullous diseases: pathogenesis and clinical management
10.1186/s43556-025-00272-9 · ExternalCitation · doi-reference
Oral lichen planus treated with plasma rich in growth factors
10.12788/cutis.0468 · ExternalCitation · doi-reference
Characterization of skin reactions and pain reported by patients receiving radiation therapy for cancer at different sites
10.12788/j.suponc.0009 · ExternalCitation · doi-reference
Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study
10.1302/0301-620x.89b3.18491 · ExternalCitation · doi-reference
Inside the mucosal immune system
10.1371/journal.pbio.1001397 · ExternalCitation · doi-reference
IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway
10.1371/journal.pone.0028663 · ExternalCitation · doi-reference
Heterogeneity of inflammatory and cytokine networks in chronic plaque psoriasis
10.1371/journal.pone.0034594 · ExternalCitation · doi-reference
The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma
10.1371/journal.pone.0136789 · ExternalCitation · doi-reference
Psychosocial impact of skin diseases: a population-based study
10.1371/journal.pone.0244765 · ExternalCitation · doi-reference
Gene signatures associated with barrier dysfunction and infection in oral lichen planus identified by analysis of transcriptomic data
10.1371/journal.pone.0257356 · ExternalCitation · doi-reference
CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production
10.1371/journal.ppat.1006196 · ExternalCitation · doi-reference
Injectable platelet-rich fibrin promotes proliferation and trichogenic inductivity of dermal papilla cells through activating TGF-β/Smad signaling pathway
10.14715/cmb/2024.70.4.25 · ExternalCitation · doi-reference
Intralesional platelet-rich plasma injection in patients with recalcitrant alopecia areata
10.14744/semb.2025.63444 · ExternalCitation · doi-reference
Platelet rich plasma: a short overview of certain bioactive components
10.1515/med-2016-0048 · ExternalCitation · doi-reference
Platelet-rich plasma in alopecia areata: intradermal injection versus topical application with transepidermal delivery via either fractional carbon dioxide laser or microneedling
10.15570/actaapa.2020.35 · ExternalCitation · doi-reference
Efficacy of injectable platelet-rich fibrin in the erosive oral lichen planus: a split-mouth, randomized, controlled clinical trial
10.1590/1678-7757-2021-0180 · ExternalCitation · doi-reference
The efficacy and safety of autologous activated platelet-rich plasma therapy as adjuvant treatment of atopic dermatitis in pregnant woman
10.17532/jhsci.2023.2178 · ExternalCitation · doi-reference
kamarthi N, Sumit G, Sangeeta M, Swati G, Abhinav S. Comparative evaluation of autologous platelet rich plasma and triamcinolone acetonide injection in the management of erosive lichen planus and oral submucous fibrosis: a clinical study
10.18203/2319-2003.ijbcp20231125 · ExternalCitation · doi-reference
Intralesional triamcinolone acetonide versus platelet rich plasma: a comparative study in the treatment of alopecia areata of scalp
10.18203/issn.2455-4529.intjresdermatol20193223 · ExternalCitation · doi-reference
Role of intralesional platelet-rich plasma (PRP) therapy in the treatment of recalcitrant oral ulcers of pemphigus vulgaris
10.18231/j.ijced.2024.077 · ExternalCitation · doi-reference
Psoriasis: an update on topical and systemic therapies
10.18773/austprescr.2025.026 · ExternalCitation · doi-reference
Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties
10.1902/jop.2007.060302 · ExternalCitation · doi-reference
10.19746/j.cnki.issn.1009-2137.2023.05.037
10.19746/j.cnki.issn.1009-2137.2023.05.037 · ExternalCitation · doi-reference
Angiogenesis and tissue repair depend on platelet dosing and bioformulation strategies following orthobiological platelet-rich plasma procedures: a narrative review
10.20944/preprints202306.0745.v1 · ExternalCitation · doi-reference
Variability in platelet-rich plasma preparations used in regenerative medicine: a comparative analysis
10.21203/rs.3.rs-1423315/v1 · ExternalCitation · doi-reference
An autologous topical serum derived from platelet-rich plasma therapy for the management of sensitive skin alterations: a case series report
10.2147/ccid.s379323 · ExternalCitation · doi-reference
Epidemiology of invasive candidiasis
10.2147/clep.s459600 · ExternalCitation · doi-reference
The usefulness of platelet-rich plasma (PRP) for the treatment of vitiligo: state of the art and review
10.2147/dddt.s239912 · ExternalCitation · doi-reference
Platelet rich plasma and its use in hair regrowth: a review
10.2147/dddt.s356858 · ExternalCitation · doi-reference
Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds
10.2147/idr.s186651 · ExternalCitation · doi-reference
Mechanisms underlying lichen planus in association with biologic therapy
10.2147/jir.s554375 · ExternalCitation · doi-reference
Efficacy and safety of pulsed radiofrequency combined with platelet-rich plasma in the treatment of postherpetic neuralgia: a systematic review and meta-analysis
10.2147/jpr.s548797 · ExternalCitation · doi-reference
Evaluation of platelet rich plasma in the management of psoriasis
10.21608/bjas.2018.179330 · ExternalCitation · doi-reference
Clinical evaluation of the efficiency of intralesional injection of autologous platelet rich plasma in treatment of erosive oral lichen planus
10.21608/edj.2021.51346.1366 · ExternalCitation · doi-reference
Efficacy and safety of platelet lysate mucoadhesive gel in the treatment of patients suffering from an erosive form of oral lichen planus: a randomized placebo-controlled clinical trial
10.21608/edj.2022.146525.2166 · ExternalCitation · doi-reference
Interleukin 17 expression in psoriatic skin lesions before and after treatment with platelet rich plasma (PrP)
10.21608/mjcu.2018.56346 · ExternalCitation · doi-reference
Pathogenesis of atopic dermatitis: current paradigm
10.22034/iji.2019.80253 · ExternalCitation · doi-reference
Pure platelet-rich plasma and supernatant of calcium-activated P-PRP induce different phenotypes of human macrophages
10.2217/rme-2017-0122 · ExternalCitation · doi-reference
Alterations in factors involved in differentiation and barrier function in the epithelium in oral and genital lichen planus
10.2340/00015555-2533 · ExternalCitation · doi-reference
Socioeconomic status and the prevalence of skin and atopic diseases in five European countries
10.2340/00015555-3082 · ExternalCitation · doi-reference
Out-of-pocket costs for individuals with atopic eczema: a cross-sectional study in nine European countries
10.2340/00015555-3102 · ExternalCitation · doi-reference
Counting the burden: atopic dermatitis and health-related quality of life
10.2340/00015555-3511 · ExternalCitation · doi-reference
Sex differences in dermatology life quality index (DLQI) among patients with psoriasis
10.2340/actadv.v104.42441 · ExternalCitation · doi-reference
Oral lichen planus: therapy and phenotype
10.23736/s0392-0488.16.05399-2 · ExternalCitation · doi-reference
Recalcitrant oral involvement in pemphigus vulgaris successfully treated with platelet-rich plasma
10.23736/s2784-8671.20.06664-x · ExternalCitation · doi-reference
Topical applications of heterologous platelet rich plasma (PRP) for refractory gingival lesions in autoimmune blistering diseases
10.23736/s2784-8671.23.07696-x · ExternalCitation · doi-reference
Platelet-rich plasma for the treatment of alopecia: a systematic review and meta-analysis
10.2450/2021.0216-2 · ExternalCitation · doi-reference
Platelet rich plasma use for treatment of acne scars: an overview of systematic reviews
10.2450/bloodtransfus.536 · ExternalCitation · doi-reference
First use of cord blood platelet-rich plasma in the treatment of vulvar lichen sclerosus: a preliminary study towards a randomized controlled trial
10.2450/bloodtransfus.875 · ExternalCitation · doi-reference
Improvement of rosacea by injection of platelet-rich plasma
10.25056/jcm.2019.3.2.125 · ExternalCitation · doi-reference
Triple combination of fractional carbon dioxide laser, 308-nm excimer lamp, and platelet-rich plasma in refractory vitiligo: a randomized split-body comparative study
10.25259/jcas_16_2024 · ExternalCitation · doi-reference
The biology of the platelet with special reference to inflammation, wound healing and immunity
10.2741/4613 · ExternalCitation · doi-reference
Human skin basement membrane in health and in autoimmune diseases
10.2741/a196 · ExternalCitation · doi-reference
Comparing the efficacy of intra-dermal platelet rich plasma (PRP) versus 50% trichloracetic acid (TCA) using cross technique for atrophic acne scars
10.29271/jcpsp.2021.01.55 · ExternalCitation · doi-reference
Platelet-rich plasma prolongs myofibroblast accumulation in corneal stroma with incisional wound
10.3109/02713683.2014.978478 · ExternalCitation · doi-reference
The role of platelet-rich plasma in tissue regeneration
10.3109/09537104.2012.684730 · ExternalCitation · doi-reference
Women and autoimmune diseases
10.3201/eid1011.040367 · ExternalCitation · doi-reference
The diagnosis and treatment of autoimmune blistering skin diseases
10.3238/arztebl.2011.0399 · ExternalCitation · doi-reference
Platelet-rich plasma in peripheral nerve injury repair: a comprehensive review of mechanisms, clinical applications, and therapeutic potential
10.3389/ebm.2025.10746 · ExternalCitation · doi-reference
Platelet-rich plasma attenuates the severity of joint capsule fibrosis following post-traumatic joint contracture in rats
10.3389/fbioe.2022.1078527 · ExternalCitation · doi-reference
Platelet-rich plasma may accelerate diabetic wound healing by modulating epithelial/endothelial-mesenchymal transition through inhibiting reactive oxygen species-mediated oxidative stress
10.3389/fbioe.2025.1623780 · ExternalCitation · doi-reference
Platelet-rich plasma (PRP) bidirectionally modulates scar formation via the Piezo1-YAP/TAZ axis: a novel mechanotransduction hypothesis
10.3389/fcell.2026.1734266 · ExternalCitation · doi-reference
In vitro antibacterial activity of platelet-rich plasma against gram-positive and gram-negative pathogens
10.3389/fcimb.2026.1757780 · ExternalCitation · doi-reference
Fresh evidence for platelets as neuronal and innate immune cells: their role in the activation, differentiation, and deactivation of Th1, Th17, and tregs during tissue inflammation
10.3389/fimmu.2018.00406 · ExternalCitation · doi-reference
Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences
10.3389/fimmu.2018.00579 · ExternalCitation · doi-reference
Skin barrier and autoimmunity-mechanisms and novel therapeutic approaches for autoimmune blistering diseases of the skin
10.3389/fimmu.2019.01089 · ExternalCitation · doi-reference
Adaptive and innate immunity in psoriasis and other inflammatory disorders
10.3389/fimmu.2019.01764 · ExternalCitation · doi-reference
Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid
10.3389/fimmu.2023.1159351 · ExternalCitation · doi-reference
Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches
10.3389/fimmu.2024.1361005 · ExternalCitation · doi-reference
Immunoregulatory role of platelet derivatives in the macrophage-mediated immune response
10.3389/fimmu.2024.1399130 · ExternalCitation · doi-reference
Therapeutic strategies focusing on immune dysregulation and neuroinflammation in rosacea
10.3389/fimmu.2024.1403798 · ExternalCitation · doi-reference
Editorial: epithelial immune microenvironment and inflammatory skin diseases
10.3389/fimmu.2024.1428209 · ExternalCitation · doi-reference
Advances in the pathogenesis of rosacea
10.3389/fimmu.2025.1595493 · ExternalCitation · doi-reference
Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
10.3389/fimmu.2025.1692916 · ExternalCitation · doi-reference
Psoriasis: microbiome dysbiosis and pathogenic mechanisms
10.3389/fimmu.2026.1714515 · ExternalCitation · doi-reference
Combined effect of microneedling and platelet-rich plasma for the treatment of acne scars: a meta-analysis
10.3389/fmed.2021.788754 · ExternalCitation · doi-reference
Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: a systematic review
10.3389/fmed.2022.1058431 · ExternalCitation · doi-reference
The burden of living with cutaneous lupus erythematosus
10.3389/fmed.2022.897987 · ExternalCitation · doi-reference
Lichen sclerosus: the 2023 update
10.3389/fmed.2023.1106318 · ExternalCitation · doi-reference
Shame and disgust in patients with inflammatory skin diseases: a systematic review of psychological correlates and psychotherapeutic approaches
10.3389/fmed.2025.1620940 · ExternalCitation · doi-reference
Colonization with staphylococcus aureus in atopic dermatitis patients: attempts to reveal the unknown
10.3389/fmicb.2020.567090 · ExternalCitation · doi-reference
Autologous platelet-rich gel versus vitamin B12 for the treatment of grade III-IV acute radiation dermatitis in malignant tumor patients undergoing radiotherapy: an open-label randomized controlled clinical trial
10.3389/fonc.2025.1576458 · ExternalCitation · doi-reference
del Olmo-Aguado S, García-Pérez E, Fernández-Vega-Cueto L, Fernández-Vega Cueto A, Baamonde-Arbaiza B, et al. Plasma rich in growth factors promotes autophagy in ARPE19 cells in response to oxidative stress induced by blue light
10.3390/biom11070954 · ExternalCitation · doi-reference
Platelet-rich plasma (PRP) in dermatology: cellular and molecular mechanisms of action
10.3390/biomedicines12010007 · ExternalCitation · doi-reference
Platelet-rich plasma (PRP) rinses for the treatment of non-responding oral lichen planus: a case report
10.3390/biomedicines6010015 · ExternalCitation · doi-reference
Platelet-derived GARP induces peripheral regulatory T cells-potential impact on T cell suppression in patients with melanoma-associated thrombocytosis
10.3390/cancers12123653 · ExternalCitation · doi-reference
The epidemiology of acne in the current era: trends and clinical implications
10.3390/cosmetics12030106 · ExternalCitation · doi-reference
Increased expression of angiopoietin 2 and Tie2 in Rosacea
10.3390/dermatopathology13010002 · ExternalCitation · doi-reference
Oral pemphigoid recalcitrant lesion treated with PRGF infiltration. Case report
10.3390/dj9110137 · ExternalCitation · doi-reference
The burden of hidradenitis suppurativa signs and symptoms in quality of life: systematic review and meta-analysis
10.3390/ijerph18136709 · ExternalCitation · doi-reference
Psoriasis pathogenesis and treatment
10.3390/ijms20061475 · ExternalCitation · doi-reference
The dynamics of the skin's immune system
10.3390/ijms20081811 · ExternalCitation · doi-reference
Systematic review-the potential implications of different platelet-rich plasma (PRP) concentrations in regenerative medicine for tissue repair
10.3390/ijms21165702 · ExternalCitation · doi-reference
Leucocyte-rich platelet-rich plasma enhances fibroblast and extracellular matrix activity: implications in wound healing
10.3390/ijms21186519 · ExternalCitation · doi-reference
The risk of systemic diseases in those with psoriasis and psoriatic arthritis: from mechanisms to clinic
10.3390/ijms21197041 · ExternalCitation · doi-reference
Effect of platelet-rich plasma on M1/M2 macrophage polarization
10.3390/ijms22052336 · ExternalCitation · doi-reference
Synopsis of barrier function of skin and oral mucosa-volume 1
10.3390/ijms22179383 · ExternalCitation · doi-reference
Skin barrier dysregulation in psoriasis
10.3390/ijms221910841 · ExternalCitation · doi-reference
The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications
10.3390/ijms222312793 · ExternalCitation · doi-reference
Platelet derivatives and the immunomodulation of wound healing
10.3390/ijms23158370 · ExternalCitation · doi-reference
microRNAs are abundant and stable in platelet-rich fibrin and other autologous blood products of canines
10.3390/ijms24010770 · ExternalCitation · doi-reference
Action of platelet-rich plasma on in vitro cellular bioactivity: more than platelets
10.3390/ijms24065367 · ExternalCitation · doi-reference
Advances in platelet rich plasma-derived extracellular vesicles for regenerative medicine: a systematic-narrative review
10.3390/ijms241713043 · ExternalCitation · doi-reference
Platelets rich plasma increases antioxidant defenses of tenocytes via Nrf2 signal pathway
10.3390/ijms241713299 · ExternalCitation · doi-reference
Synopsis of barrier function of skin and mucosa-volume 2
10.3390/ijms241813690 · ExternalCitation · doi-reference
Elevated IL-1β and comparable IL-1 receptor antagonist levels are characteristic features of L-PRP in female college athletes compared to male professional soccer players
10.3390/ijms242417487 · ExternalCitation · doi-reference
Pathogenesis of inflammation in skin disease: from molecular mechanisms to pathology
10.3390/ijms251810152 · ExternalCitation · doi-reference
Unveiling the microbiome's role in hidradenitis suppurativa: a comprehensive review of pathogenetic mechanisms
10.3390/ijms26199542 · ExternalCitation · doi-reference
Platelet-rich plasma (PRP): molecular mechanisms, actions and clinical applications in human body
10.3390/ijms262110804 · ExternalCitation · doi-reference
Platelet-rich plasma and acellular dermal matrix in the surgical treatment of hidradenitis suppurativa: a comparative retrospective study
10.3390/jcm12062112 · ExternalCitation · doi-reference
Potential role of innate lymphoid cells in the pathogenesis and treatment of skin diseases
10.3390/jcm12083043 · ExternalCitation · doi-reference
Effectiveness of platelet-rich plasma injections as prophylaxis for recurrent urinary tract infection in women
10.3390/jcm12124129 · ExternalCitation · doi-reference
The spectrum of cutaneous manifestations in lupus erythematosus: a comprehensive review
10.3390/jcm13082419 · ExternalCitation · doi-reference
Vitiligo: from pathogenesis to treatment
10.3390/jcm13175225 · ExternalCitation · doi-reference
Platelet-rich concentrates in the management of lichen planus—a comprehensive review
10.3390/jcm14155368 · ExternalCitation · doi-reference
Hair transplantation for lichen planopilaris: a case series of five patients
10.3390/jcm14176199 · ExternalCitation · doi-reference
Platelet-rich plasma (PRP) and recombinant growth factor therapies in cutaneous wound healing: mechanisms, clinical applications, and future directions
10.3390/jcm14238583 · ExternalCitation · doi-reference
Autologous matrix of platelet-rich fibrin in wound care settings: a systematic review of randomized clinical trials
10.3390/jfb11020031 · ExternalCitation · doi-reference
Role of oral microbiota dysbiosis in the development and progression of oral lichen planus
10.3390/jpm14040386 · ExternalCitation · doi-reference
Platelet-rich plasma in dermatology: new insights on the cellular mechanism of skin repair and regeneration
10.3390/life14010040 · ExternalCitation · doi-reference
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management
10.3390/medicina57090895 · ExternalCitation · doi-reference
Pilot study on the use of the “Monocyte-Rich” platelet-rich plasma in combination with 1927 nm fractional and 308 nm excimer lasers for the treatment of vitiligo
10.3390/medicina57090904 · ExternalCitation · doi-reference
An updated review of pemphigus diseases
10.3390/medicina57101080 · ExternalCitation · doi-reference
Efficacy of platelet-rich plasma therapy in oral lichen planus: a systematic review
10.3390/medicina59040746 · ExternalCitation · doi-reference
Adult-onset linear morphea (en coupe de sabre) of the face successfully treated with photoactivated low-temperature platelet-rich plasma: a valid therapeutic option
10.3390/medicina59061114 · ExternalCitation · doi-reference
Restoration of skin barrier abnormalities with IL4/13 inhibitors and jak inhibitors in atopic dermatitis: a systematic review
10.3390/medicina60081376 · ExternalCitation · doi-reference
Genital lichen sclerosus-the role of the vulvar microbiome
10.3390/medicina61091632 · ExternalCitation · doi-reference
Microbiota and immune-mediated skin diseases-an overview
10.3390/microorganisms7090279 · ExternalCitation · doi-reference
Real-world data on severe cutaneous adverse reactions to drugs
10.3390/ph19010021 · ExternalCitation · doi-reference
Platelet rich plasma and adipose-derived mesenchymal stem cells mitigate methotrexate-induced nephrotoxicity in rat via Nrf2/Pparγ/HO-1 and NF-?
10.3390/toxics11050398 · ExternalCitation · doi-reference
Dermatitis; types, causes, symptoms and management: a review
10.35702/derm.10016 · ExternalCitation · doi-reference
Effectiveness of platelet-rich plasma gel alongside tacrolimus ointment in managing erosive oral lichen planus and its effect on oral immune microenvironment
10.36721/pjps.2024.37.6.reg.1625-1633.1 · ExternalCitation · doi-reference
Platelet rich plasma for the treatment of scarring alopecia due to discoid lupus erythematosus
10.36849/jdd.5933 · ExternalCitation · doi-reference
Y FY, S D. Application of topical autologous platelet-rich plasma for treatment of pemphigus foliaceus wounds: a case report bioscientia medicina
10.37275/bsm.v6i12.625 · ExternalCitation · doi-reference
Comparative evaluation of intralesional injection of autologous platelet rich plasma versus intralesional injection of corticosteroids in the management of resistant oral lichen planus
10.37506/ijocd.v11i2.20053 · ExternalCitation · doi-reference
US health care disparities in immunology biologics access: a systematic review
10.37765/ajmc.2025.89774 · ExternalCitation · doi-reference
PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP
10.3791/50351 · ExternalCitation · doi-reference
Comparative evaluation of the effects of platelet-rich plasma formulations on extracellular matrix formation and the NF-κB signaling pathway in human articular chondrocytes
10.3892/mmr.2017.6365 · ExternalCitation · doi-reference
Atopic dermatitis in children
10.3928/19382359-20240205-02 · ExternalCitation · doi-reference
Activated platelets enhance IL-10 secretion and reduce TNF-α secretion by monocytes
10.4049/jimmunol.1201103 · ExternalCitation · doi-reference
Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses
10.4049/jimmunol.169.3.1535 · ExternalCitation · doi-reference
Platelets, after exposure to a high shear stress, induce IL-10-producing, mature dendritic cells in vitro
10.4049/jimmunol.172.9.5297 · ExternalCitation · doi-reference
Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions
10.4049/jimmunol.178.9.5571 · ExternalCitation · doi-reference
The role of memory CD8(+) T cells in vitiligo
10.4049/jimmunol.1900027 · ExternalCitation · doi-reference
Regenerative therapies in lichen sclerosus genitalis patients and possible efficacy in preventing squamous cell carcinoma development: a long-term follow-up pilot study
10.4081/dr.2024.10079 · ExternalCitation · doi-reference
Role of platelet-rich plasma in chronic alopecia areata: our centre experience
10.4103/0970-0358.155271 · ExternalCitation · doi-reference
Successful hair transplant outcome in cicatricial lichen planus of the scalp by combining scalp and beard hair along with platelet rich plasma
10.4103/0974-2077.178562 · ExternalCitation · doi-reference
Hidradenitis suppurativa: consequences of microbiome dysbiosis on immune dysregulation and disease severity
10.4103/ijd.ijd_623_21 · ExternalCitation · doi-reference
Halting the progression of cicatricial alopecia with injectable platelet-rich fibrin
10.4103/ijt.ijt_116_21 · ExternalCitation · doi-reference
Therapeutic efficacy of a plasma rich in growth factors gel combined with fractional ablative laser in the management of post-acne scars
10.4103/jcas.jcas_160_21 · ExternalCitation · doi-reference
Comparative evaluation of therapeutic efficacy of intralesional injection of triamcinolone acetonide versus intralesional autologous platelet-rich plasma injection in alopecia areata
10.4103/jcas.jcas_16_19 · ExternalCitation · doi-reference
Microneedling with PRP for acne scars: a new tool in dermatologist arsenal - a scoping review
10.4103/jpbs.jpbs_804_23 · ExternalCitation · doi-reference
Adjunct treatment with platelet-rich plasma for the treatment of inflammatory alopecia in an adult filipino female with systemic lupus erythematosus
10.4103/jpds.jpds_33_24 · ExternalCitation · doi-reference
Effects of intralesional platelets-rich plasma injections on oral lichen planus lesions and salivary interleukin-8
10.4103/mjbl.mjbl_359_22 · ExternalCitation · doi-reference
Mucoadhesive mycophenolate mofetil and injectable platelet rich fibrin in the treatment of oral lichen planus
10.4103/tdj.tdj_34_24 · ExternalCitation · doi-reference
Immunopathology and immunotherapy of inflammatory skin diseases
10.4110/in.2022.22.e7 · ExternalCitation · doi-reference
Th pathways in immune-mediated skin disorders: a guide for strategic treatment decisions
10.4110/in.2024.24.e33 · ExternalCitation · doi-reference
The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis
10.4161/jkst.24137 · ExternalCitation · doi-reference
Significance of skin barrier dysfunction in atopic dermatitis
10.4168/aair.2018.10.3.207 · ExternalCitation · doi-reference
Rodríguez-de Rivera-Campillo ME, Otero-Rey EM, Estrugo-Devesa A, Jané-Salas E, López-López J. Oral lichen planus and its relationship with systemic diseases. A review of evidence
10.4317/jced.55145 · ExternalCitation · doi-reference
Management of atopic dermatitis: a narrative review
10.5694/mja2.51560 · ExternalCitation · doi-reference
Management of lichen sclerosus and related comorbidities at a tertiary referral center: beyond topical steroids
10.5826/dpc.1404a262 · ExternalCitation · doi-reference
Efficacy of intralesional injection of platlet rich plasma in combination with methoterexate in chronic plaque psoriasis
10.66344/jpad.v32i2.1854 · ExternalCitation · doi-reference
Can platelet-rich plasma reduce the burden of inflammatory skin diseases such as psoriasis and atopic dermatitis?
10.7759/cureus.18472 · ExternalCitation · doi-reference
Platelet-rich plasma in alopecia areata: a case report with a mini review of literature
10.7759/cureus.38751 · ExternalCitation · doi-reference
Current status and advancements in platelet-rich plasma therapy
10.7759/cureus.47176 · ExternalCitation · doi-reference
Platelet-rich plasma for the treatment of plaque psoriasis: a systematic review
10.7759/cureus.50356 · ExternalCitation · doi-reference
Antimicrobial effects of platelet-rich plasma and platelet-rich fibrin: a scoping review
10.7759/cureus.51360 · ExternalCitation · doi-reference
Platelet-rich plasma in aesthetic dermatology: current evidence and future directions
10.7759/cureus.66734 · ExternalCitation · doi-reference
Lagrán Z, Alkhraisat MH. Bioactive effect of plasma-rich in growth factors (PRGFs) on cell-based in vitro models of skin inflammation in relation to inflammatory skin disorders
10.7759/cureus.74252 · ExternalCitation · doi-reference
Alopecia areata: understanding the pathophysiology and advancements in treatment modalities
10.7759/cureus.78298 · ExternalCitation · doi-reference
Skin barrier dysfunction in chronic dermatoses: from pathophysiology to emerging therapeutic strategies
10.7759/cureus.86937 · ExternalCitation · doi-reference
The burden of skin disease: quality of life, economic aspects and social issues
10.7861/clinmedicine.9-6-592 · ExternalCitation · doi-reference